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ABSTRACT
PATHOGENICITY OF MURINE CYTOMEGALOVIRUS MUTANTS
V ictoria Jean Cavanaugh
Eastern V irginia Medical School and Old D om inion University, 1995
D irector: Dr. Ann E. Campbell

Cytomegaloviruses (CMV) are species-specific DNA viruses th a t belong to
the P-herpesvirus subfam ily, and persist in their hosts for life following prim aiy
infection. P rim aiy infection in the im m unocom petent host is usually
asym ptom atic, however, CMV can cause severe disease and death in the
immunocompromised host. To better understand the pathogenic mechanisms
o f CMV infection, those viral gene products involved in virus-host interactions
m ust be identified. V ira l genes th a t are not required fo r virus replication in
cultured cells are termed nonessential genes. It is these nonessential viral
genes th a t probably encode pathogenic factors and play a critica l role in virushost interactions and pathogenesis in vivo, even though they are dispensable for
virus growth in intro. The purpose o f th is study was to identify7nonessential
m urine CMV (MCMV) genes involved in pathogenesis in vivo. O ur approach to
identifying these genes consisted o f constructing MCMV m utants, and then
analyzing these m utants in vitro and in vivo. Recombinant viruses (RV)
expressing the p-glucuronidase m arker gene were constructed by site-directed
insertion and deletion mutagenesis o f the MCMV H ind III-J and -I regions o f the
v ira l genome. M utations were targeted to th is region o f the MCMV genome
because the corresponding region o f the hum an CMV genome is nonessential

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

and is involved in down-regulating m ajor histocom patibility complex (MHC)
class I expression in infected hum an cells. Four m utant viruses were created:
RV5, an insertion m utant in H ind III-J ; RV6, a deletion m utant missing 2.8
kilobase (kb) pairs from H ind III-J ; RV7, a deletion m utant lacking 7.7 kb from
Hind III-J and -I; and RV9, a deletion m utant m issing 10.7 kb from Hind III-J
and -I. RV9 is a helper-dependent virus, and therefore, was not included in
subsequent experiments. In vitro, RV5, RV6, and RV7 grew sim ilarly to w ildtype (WT) MCMV in NIH3T3 fibroblasts and in p rim a iy embryo fibroblasts,
confirm ing th a t the m utations introduced into these viruses are nonessential
for MCMV replication in cultured fibroblasts. In IC-21 macrophages, RV5 and
RV6 grew sim ilarly to WT virus, however, RV7 grew 2 to 3 logs lower. A onestep growth curve o f RV7 in these macrophages indicated th a t the reduced
growth o f th is m u ta n t virus was prim arily due to a defect in virus replication.
N orthern blo t analyses o f immediate-early (IE), early, and late RNAs
demonstrated th a t the block in RV7 replication occured a t the IE phase o f virus
replication. A sim ultaneous Southern blot analysis o f RV7-infected IC-21
macrophages indicated th a t RV7 entered these cells as efficiently as WT MCMV.
Therefore, poor replication o f RV7 in these cells is not the result o f a defect in
virus entry, b u t instead is due to inadequate IE vira l gene expression. These
data are highly significant because interactions between CMV and macrophages
play a c ritic a l role in pathogenesis in vivo, particularly in virus dissem ination
and latency. The MCMV m utants were analyzed by Western blot w ith an
antibody to the H-2Kb class I heavy chain to determine if sequences w ithin Hind
III-J o r -I were involved in the down-regulation o f MHC class I expression
observed in WT-infected cells. RV5, RV6, and RV7 significantly reduced the
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level o f the class I heavy chain in infected fibroblasts, indicating th a t th is
nonessential region o f the MCMV genome is not involved in class I downregulation. In infected mice, a ll o f the MCMV m utants displayed significantly
reduced growth in the salivaiy glands, an organ central to the biology o f CMV.
In fact, the growth o f RV7 in the salivary glands was barely detectable,
indicating th a t the genes deleted from these viruses are required for the efficient
replication o f MCMV in the salivary gland.
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I. INTRODUCTION
Cytomegaloviruses
Cytomegaloviruses (CMV) are ubiquitous DNA viruses th a t infect a wide
range o f anim al species, including hum ans (Staczek, 1990). These viruses
belong to the fam ily Herpesviridae, and more specifically to the subfam ily
Betaherpesvirinae (Roizman, 1990a). Characteristics o f the members o f th is

subfam ily include: s tric t species specificity, a relatively long replication cycle,
and a slowly developing cytopathology characterized by cytomegaly, or an
enlargement o f the infected cell. In hum an and other anim al populations, the
incidence o f infection w ith CMV can approach 100% (Alford and B ritt, 1990).
In healthy individuals, CMV is nonpathogenic, and prim ary infection is not
accompanied by apparent disease. Following prim ary infection, CMV persists in
its host for life, manifested as asymptomatic productive infection o r viral
latency. CMV reveals its pathogenic capabilities in the immunocompromised
host. The virus can cause severe disease, and even death, in those individuals
w ith im m ature immune systems, such as the fetus and newborn, or in those
w ith suppressed immune systems, such as patients w ith AIDS or those
receiving immunosuppressive treatm ents fo r either cancer or organ
transplantation.
H istorical Perspective
Infection w ith CMV characteristically produces cytomegaly w ith
intranuclear inclusions (Staczek, 1990). H istorically (historical accounts
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reviewed in A lford and B ritt, 1990 and Staczek, 1990), one o f the earliest
reports describing th is cytopathology was published in 1904 by Jesionek and
Kiolemenoglou who examined several organs o f a newborn infa nt thought to
have died o f syphilis. S im ilar reports o f these cytomegalic cells observed in the
tissues o f other patients w ith fa ta l infection led to the early designation o f
“cytomegalic inclusion disease”, o r CID, even before the causative agent was
identified. Many early investigators believed th a t the intranuclear inclusions
were the re su lt o f parasitic or protozoan infections. A vira l etiology fo r CID was
firs t proposed in 1921 by Lipschutz, who recognized th a t sim ilar inclusions
were also observed in herpetic lesions. In the same year, Goodpasture and
Talbot reported the sim ila rity of cytomegalic cells found in the parotid glands o f
infants studied a t autopsy to those found in the parotid glands of guinea pigs.
In 1926, Cole and K u ttne r provided the firs t experim ental evidence th a t the
causative agent o f CID was a virus. Using a guinea pig model, they showed
th a t filtered homogenates o f inclusion-bearing salivary glands from a d ult
anim als were infectious fo r inclusion-free younger animals. They also
demonstrated th a t the infectious agent was species specific. Because the
disease, in both anim als and hum ans, was associated w ith infection o f the
salivary glands, the causative agent was termed “salivary gland virus” .
In 1954, Sm ith succeeded in isolating and propagating the mouse
salivary gland viru s in mouse embryonic fibroblasts (Smith, 1954). Two years
later, the hum an virus was isolated independently by three different
investigators (reviewed in Alford and B ritt, 1990). Sm ith isolated the virus from
the salivary gland o f an in fa n t dying o f generalized CID. Rowe and his
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coworkers isolated three strains o f the hum an virus from the adenoidal tissue o f
children who underwent to n sil and adenoidectomies. Strain AD 169, a
commonly used laboratoiy adapted strain, originated from these studies. And
W eller and colleagues recovered the hum an virus from the urine o f a living
in fa n t w ith generalized CID (Weller et. al., 1957). It was Weller who coined the
term “cytomegalovirus” to describe the cellular changes produced by these
viruses.
V irion Structure
The virion structure o f CMV, like th a t o f a ll herpesviruses, consists o f:
1) an inner core, containing the linear, double-stranded DNA genome complexed
helically w ith protein, 2) a capsid enclosing the genome and consisting o f a to ta l
o f 162 protein capsomere subunits arranged in an icosadeltahedral shape (20
surfaces), 3) a tegument, or amorphous m aterial surrounding the capsid, and 4)
an envelope, or outer covering, derived from patches o f cellular membrane
containing vira l glycoprotein spikes (Roizman, 1990a). The virions are
pleomorphic and have a diameter o f between 150 and 300 nanometers, due to
variability in the thickness o f the tegum ent (G riffiths and Grundy, 1987).
V ira l Genome
CMV has the largest and m ost complex genome o f any known virus
(Stinski, 1990). The genomes o f both hum an CMV (HCMV) and m urine CMV
(MCMV) are approxim ately 230 kilobase pairs in length, and are estimated to
encode over 200 genes (Chee et. al., 1990; Rawlinson et. al., 1993).
The genomic structure o f anim al CMVs vary according to the presence
or absence o f term inal and internal reiterated sequences (Roizman, 1990a). For
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example, in the HCMV genome, sequences from both te rm ini are repeated in an
inverted orientation and juxtaposed internally, dividing the genome into two
unique components, each flanked by inverted repeats (Stinski, 1990) (shown in
Fig. 1). The unique components, termed the unique long (Ul) and the unique
short (Us) regions, can in ve rt relative to each other du rin g virus replication,
giving rise to four genomic isomers. V irions can contain any one o f these four
isomers, and viral DNA extracted from infected cells o r virions consists o f
equim olar concentrations o f a ll four isomers. In contrast, the MCMV genome
consists prim arily o f unique sequences w ith no repeat sequences, and therefore
does not isomerize (see Fig. 1).
V iral Replication
Infection o f cells by CMV does not guarantee th a t viral m ultiplication w ill
occur, o r th a t viral progeny w ill be produced. Infection w ith CMV can be
productive, abortive, restrictive, or latent (reviewed in Roizman, 1990b). A
productive infection occurs in permissive cells, and results in the production of
infectious progeny. An abortive infection can occur in nonpermissive cells, in
which case some, b u t not a ll, virus genes are expressed; or can result from
infection w ith defective viruses, w hich lack viral genes required for progeny
production. A restrictive infection can occur in a transiently permissive cell,
resulting in virus persistence inside the cell u n til the cell becomes permissive,
or in only a few' cells in a population producing vira l progeny a t any one time.
And lastly, a latent infection occurs when the viral genome is m aintained inside
the cell w itho u t the production o f any infectious virus particles.

4
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The general pattern of CMV replication in a fu lly permissive cell is as
follows (reviewed in Stinski, 1990). Infection is initiated when the virus
attaches to receptors on the surface o f the cell. Penetration occurs alm ost
instantaneously after attachm ent, and involves fusion o f the cellular membrane
w ith the virio n envelope. The attachm ent and penetration phases o f CMV
infection are complex, and require the coordinated participation o f m ultiple
cellular and vira l components. The in itia l event in HCMV infection is
attachm ent o f the virio n to extracellular heparin sulfate proteoglycans
(Compton et. al., 1993). This in itia l interaction is absolutely required fo r virus
infection, and involves several vira l envelope proteins, including the glycoprotein
B (gB). The binding o f envelope glycoproteins to cell surface heparin sulfate
then facilitates high a ffin ity binding to a cellular receptor(s). HCMV specifically
binds to 32- and 34-kilodalton (kd) membrane glycoproteins present on the
surface o f a variety o f cell types, including cells o f endothelial, epithelial,
fibroblastic, and monocytoid origins (Cooper et al., 1991; Nowlin et al., 1991).
In addition, an interaction between the HCMV glycoprotein H (gH) and a 92.5
kd cellular protein is believed to play a role in virus penetration (Keay and
Baldwin, 1991). Following penetration, the envelope o f the virus rem ains in the
plasma membrane o f the infected cell, and the internal contents o f the virion
spill into the cytoplasm.
The de-enveloped capsid is then transported along the cytoskeleton to
the nuclear pores, where the viral DNA is released into the nucleus and
immediately circularizes (Roizman, 1990b). However, it is unclear if or how the
MCMV genome circularizes, since it lacks term inal repeat sequences w hich are

5
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involved in circularization. The v ira l genomes are transcribed and replicated in
the nucleus, and the transcriptional enzymes o f the host cell are used to
generate viral mRNA. The synthesis o f vira l gene products is temporally
regulated and sequentially ordered. V iral gene expression is divided into three
general kinetic classes: immediate early (IE), early (E), and late (L) (reviewed in
Stinski, 1990).
The IE genes are the firs t to be expressed following CMV infection, and
require no p rio r v ira l protein synthesis. Cis-acting DNA elements in the
promoters o f the IE vira l genes enable the binding o f cellular transcription
factors for the in itia tio n o f IE transcription. In both HCMV and MCMV, the
promoters of the m ajor IE gene region contain an unusually strong and complex
enhancer (Dorsch-Hasler et al., 1985; Thomsen e ta l., 1984). This IE enhancer
consists o f highly conserved sets o f repeated sequence m otifs which contain
binding sites fo r cellular transcription factors, including NF-kB, ATF, and AP-1,
and provides a very strong entry site for the cellular RNA polymerase II and
other components o f the transcriptional m achinery (Ghazal et al., 1987;
M ocarski et al., 1990). In the case o f herpes simplex virus (HSV), a virion
tegument protein (VP 16), introduced into the cell following penetration, transactivates the IE vira l genes by acting in concert w ith host factors (Roizman,
1990b). HCMV also contains a virion-associated transactivator, the pp71
tegument protein encoded by the UL82 gene (Liu and S tinski, 1992). This
protein stim ulates transcription from viral and cellular promoters containing
upstream ATF sites, and enhances transcription from the m ajor IE. promoters of
both HCMV and MCMV by as m uch as 20-fold. Following immediate early

6
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transcription, the CMV mRNAs are transported into the cytoplasm and are
translated. The IE proteins are then transported back into the nucleus where
they function to stim ulate and regulate subsequent vira l gene expression.
In both HCMV and MCMV, the m ajor IE prom oter drives the expression
o f prim arily two regions, referred to as IE1 and IE2 in HCMV (Stenberg et al.,
1985; S tinski et al., 1983), and IE1 and IE3 in MCMV (Keil et al., 1987). The
m ost abundantly expressed IE gene in both viruses is the IE1 gene, w hich
encodes a protein w ith a m olecular weight o f 72 kd in HCMV (IE72) (Stenberg et
al., 1984) and 89 kd in MCMV (pp89) (Keil et al., 1985). Both IE1 gene
products are phosphoiylated nuclear proteins w ith a high percentage o f acidic
residues, and both function to transactivate cellular and vira l promoters
(Koszinowski et al., 1986; Stenberg et al., 1990). Remarkably though, there is
very' little homology between IE72 and pp89 in either nucleic acid or am ino acid
sequences (Mocarski et al., 1990). U nlike its counterpart in HCMV, pp89 o f
MCMV can bind directly to DNA, mediated by its interactions w ith core histone
proteins (Munch et al., 1991 and 1992). Interestingly, a single 9-am ino-acid
im m unodom inant epitope from pp89 induces a cytotoxic T lymphocyte (CTL)
response in BA LB /c mice th a t protects against lethal MCMV challenge (Del Val
et al., 1991). Downstream o f the IE1 gene in HCMV is the IE2 gene, w hich
encodes another regulatory protein w ith a m olecular weight o f 86 kd, and is
designated IE86 (Stenberg et al., 1989). Its MCMV counterpart, designated IE3,
has a m olecular weight o f 88-90 kd, and shows s trik in g homology to the IE86
protein in both its amino acid sequence and its regulatory functions (Messerle
et al., 1992). B oth proteins represent strong transcriptional activators o f v ira l
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and cellular promoters, and show an autoregulatoiy function by repressing the
m ajor IE promoter. In HCMV, IE72 and IE86 interact synergistically to
transactivate early vira l prom oters (Malone et al., 1990; Stenberg et al., 1989
and 1990). In MCMV, the IE1 and IE3 proteins act together to transactivate
early vira l gene expression (Buhler et al., 1990). The mRNAs encoding IE72 and
IE86 o f HCMV, as w ell as the mRNAs encoding the IE1 and IE3 proteins o f
MCMV, arise by alternative splicing. The MCMV IE2 gene represents a
divergence from th is organization, and has no known counterpart in HCMV.
This MCMV gene is located a t the other side o f the enhancer sequence, and is
transcribed in the opposite direction (Messerle et al., 1991). The MCMV IE2
gene product has no role in transcriptional activation, nor is it needed for virus
replication in m urine NIH3T3 fibroblasts (Manning and M ocarski, 1988).
The early phase o f vira l gene expression follows the immediate early
phase (reviewed in Stinski, 1990). Many E gene products are enzymes and
DNA-binding proteins involved in vira l DNA replication, and include the DNA
polymerase, the polymerase-associated protein, the m ajor-DNA-binding protein
(MDBP), and three subunits o f a helicase-primase complex (Pari and Anders,
1993). In HCMV, eleven loci are required for vira l DNA replication (Pari and
Anders, 1993). Six o f these loci encode the proteins listed above, which are
essential to initia te and perform DNA synthesis. The rem aining five loci encode
regulatory proteins required to express these factors from th e ir native
promoters, and include the IE1 /IE 2 loci. The DNA polymerases and MDBPs
from HCMV and MCMV show strikin g sim ilarity in amino acid sequence, 72%
homology fo r the MDBP and 73% homology fo r the polymerase (Messerle et al.,
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1992). This conservation points to the essential functions o f these proteins in
the replication o f the vira l DNA. The MDBP binds to and stabilizes the single
stranded DNA im m ediately after unwinding o f the double helix, and facilitates
the en tiy o f the vira l DNA polymerase and subsequent vira l DNA replication (Wu
et al., 1988). The vira l DNA polymerase is distinguished from the host enzyme
by its requirem ent fo r high salt concentrations, its sedim entation properties,
and its reversible in h ib itio n by phosphonoacetic acid (G riffiths and Grundy,
1987). D uring the early phase o f infection, the vira l DNA is replicated by a
ro lling circle mechanism th a t yeilds head-to-tail concatemers o f unit-length
vira l DNA. Because th is mechanism o f DNA replication involves the term inal
repeat sequences o f the v ira l genome, it is n o t known whether the MCMV
genome is replicated by th is method.
The last round o f transcription and translation produces the L proteins,
w hich largely represent the structural proteins o f the virion (reviewed in Stinski,
1990). These stru ctu ra l proteins include those o f the capsid, the envelope, and
the tegument, a fibrous and granular m aterial interfaced between the capsid
and the envelope. M atrix proteins represent p a rt o f the tegument and function
to anchor the envelope to the capsid. The HCMV virion contains several m atrixtegument proteins, a ll o f w hich are phosphoproteins (pp) and are designated by
th e ir m olecular weights. These m atrix proteins include pp28, pp64, pp65,
pp71, and p p l5 0 . In contrast to MCMV im m unobiology, the im m unodom inant
CTL epitopes o f HCMV are directed predom inantly against determ inants w ith in
these m atrix-tegum ent proteins, particularly pp65 and p p l5 0 (Greenberg,
1995). The pp65 m atrix protein also elicits a strong hum oral immune response,

9
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probably because th is protein is the m ost abundant virus-encoded protein,
com prising more than 50% o f the mass o f the virion (Landini et al., 1988). The
m ajor and m inor capsid proteins o f HCMV have m olecular weights o f 150 and
36-40 kd, respectively. B oth the HCMV and MCMV genomes encode a highly
conserved L gene, referred to as the ICP18.5 homolog, w hich functions in virus
assembly (Addison et al., 1990; Messerle et al., 1992).
The vira l envelope comprises a lip id bilayer membrane containing virallyencoded glycoproteins. Three o f these glycoproteins, B (gB), H (gH), and L (gL),
are conserved in amino acid sequence and te rtia iy structure among a ll
herpesviruses (Stinski, 1990; Xu et al., 1994). These glycoproteins are believed
to play critica l roles in virus attachm ent, membrane fusion events and entry,
and cell-to-cell spread (Rapp et al., 1992 and 1994). In addition, a high
proportion o f neutralizing antibodies, in both human and mouse antisera, are
directed against these glycoproteins (B ritt et al., 1990; Rapp et al., 1994; Xu et
al., 1994). In both hosts, anti-gH serum neutralizes v ira l infectivity in the
absence o f complement (Rapp et al., 1994; Rasmussen et al., 1984).
D uring the late phase o f CMV infection, the nucleocapsid proteins
assemble in the nucleus to form empty capsids (reviewed in Roizman, 1990b).
V iral DNA is then cleaved from concatamers and is packaged into the capsids.
And lastly, the envelopment and m aturation o f the virions occur a t the inner
lam ella of the nuclear membrane. The virus acquires infectivity by budding
through th is membrane, and enveloped virions accum ulate in the space
between the inner and outer lamellae o f the nuclear membrane.

10
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D uring MCMV replication, the immediate early phase represents the firs t
two to three hours o f infection, the early phase occurs between three to sixteen
hours after infection, and the late phase begins a t approxim ately sixteen hours
post-infection (Mocarski et al., 1990). Infectious vira l progeny are produced
soon after the late phase o f viru s replication begins, a t approxim ately eighteen
to twenty hours following infection.
V iral Pathogenesis
Cytomegaloviruses are species-specific viruses w ith respect to replication
and pathogenesis (Mocarski et al., 1990). In addition, only differentiated cells
appear to be fu lly permissive. Infection o f permissive cells w ith CMV is
characterized by cytomegaly, nuclear swelling, chrom atin m argination, and the
form ation o f intranuclear and intracytoplasm ic inclusions (Staczek, 1990). In a
productive infection, CMV is usually cytolytic and eventually destroys the cell in
w hich it replicates.
In norm al, healthy individuals, CMV is nonpathogenic and prim aiy
infection, w hich usually occurs during early childhood, causes little or no overt
illness (reviewed in Alford and B ritt, 1990). M ost CMV infections are
asym ptom atic because the viru s has evolved to live in equilibrium w ith its host.
A n tivira l im m une defenses function to control CMV infection (see below), and
when host immune functions are inta ct, virus replication and spread are
restricted. However, even the imm unocom petent host fails to eradicate CMV
following p rim a iy infection. Like a ll herpesviruses, CMV remains associated
w ith the infected individual fo r life, manifested either as asymptomatic
productive infection or vira l latency. D uring latency, the virus remains in a
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quiescent state, b u t can be reactivated to produce recurrent infections.
Reactivation o f latent virus is detected following im m unosuppression or
immunodeficiency, because the host im m une response is unable to contain the
recurrent infection.
The outcome o f acute CMV infection depends on the age and immune
status o f the host (reviewed in Alford and B ritt, 1990 and M ocarski et al., 1990).
CMV can cause life-threatening illnesses in those w ith im m ature or suppressed
immune systems. When im m unity is compromised, the virus represents an
opportunistic pathogen th a t is perm itted to replicate unrestricted to produce
severe or lethal disseminated disease. Individuals a t high risk for CMV disease
include the very young, such as the developing fetus or newborn, patients
undergoing immunosuppressive therapy fo r either cancer or organ
transplantation, and those w ith progressive im m unodeficiency diseases, such
as AIDS.
CMV can cross the placenta and infect the im m unologically im m ature
fetus (reviewed in Alford and B ritt, 1990). In utero transm ission can result from
either prim ary or reactivated m aternal infections, and the incidence o f
congenital CMV infection is high in comparison to other intrauterine viral
infections. Approxim ately 1% o f infants bom in the U nited States each year are
congenitally infected w ith CMV. O f these infants, approxim ately 10% show
moderate to severe symptoms, and 90% display subclinical infection. The
clinical m anifestations o f congenital CMV infection include permanent brain
damage, m ental retardation, hepatic disease and jaundice, pneumonia,
deafness, and ocular abnorm alities. Severe disseminated disease in the
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newborn is often fatal, and is characterized by widespread central nervous
system (CNS) damage and frequent occurrences o f microcephaly. Those infants
bom w ith less severe dissem inated infections usually develop significant CNS
defects in the firs t two years o f life. Congenital CMV infections are second only
to Down’s Syndrome as a known cause o f m ental retardation. Infants w ith
subclinical infections commonly e xhibit hearing loss and ocular abnorm alities,
including chorioretinitis and optic atrophy.
In immunocompromised patients, reactivation o f virus from latency
represents a m ajor cause o f m orbidity and m ortality (reviewed in Alford and
B ritt, 1990). CMV is the m ost frequent vira l pathogen following organ
transplantation, and recurrent infection occurs in approxim ately 85% o f renal
and cardiac allograft recipients. The clinical m anifestations in transplant
patients include in te rs titia l pneum onia, hepatitis, gastrointestinal hemorrhage
and ulceration, and re tin itis (Ho, 1991). CMV pneum onitis is one o f the m ajor
causes o f death in leukemia patients receiving bone m arrow transplants, and
its m o rta lity rate in these individuals is 84% (Ho, 1991).
CMV is also one o f the m ost common opportunistic pathogens in AIDS
patients, and represents a m ajor cause o f m orbidity, and often the cause o f
death, in these individuals (reviewed in Nelson et al., 1990). The diseases
caused by CMV in patients w ith AIDS include encephalitis, retinitis,
pneumonia, adrenalitis, hepatitis, and colitis. In these patients, HCMV is
believed to act as a co-factor w hich accelerates the progression o f AIDS
pathogenesis. Actually, m olecular interactions between HIV and HCMV occur
in both directions: the HIV long term inal repeat is transcriptionally activated by
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the m ajor IE proteins o f HCMV, and HCMV replication is enhanced by the
presence o f active HIV infection (Fiala et al., 1991; Nelson et al., 1990). This
synergistic role o f CMV w ith HIV is m ost evident in the brains of AIDS patients.
HCMV is present in the brains o f approxim ately one-third o f AIDS patients
(studied a t autopsy), where it infects capillary endothelial cells, m icroglial cells
(brain macrophages), and neurons (Wiley and Nelson, 1988). In these
individuals, coinfection o f the brain w ith HIV and HCMV induces a more severe
form o f dementia (called AIDS-dementia complex com plicated by CMV
encephalopathy, o r ACE) (Fiala et al., 1991).
In the im m unocom petent host, acute infection w ith CMV leads to the
productive infection o f m ost organs, including the following: salivary glands,
spleen, liver, lungs, kidneys, adrenal glands, pancreas, brain, ovaries, testes,
lym ph nodes, bone m arrow, placenta, eye, and skin (reviewed in M ocarski et al.,
1990). In vivo, CMV characteristically infects epithelial cells in these organs,
and seldomly involves fibroblasts, w hich is in stark contrast to its growth in cell
culture. D uring infection, virus produced in the salivary glands, kidneys, and
mammary tissues can be excreted in saliva, urine, and m ilk (respectively) fo r
extensive periods o f tim e. Horizontal transm ission (extrauterine) o f CMV results
from direct contact w ith these contam inated bodily secretions (reviewed in
Alford and B ritt, 1990). The dom inant routes o f transm ission during childhood
appear to be oral and respiratory, resulting from contact w ith saliva or the
inhalation or ingestion o f infected m aterial. A dditionally, CMV is present in
semen and cervical and vaginal secretions, and is spread sexually during
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puberty and adulthood. CMV can also be spread by blood transfusion or organ
transplantation from sero-positive donors to sero-negative recipients.
Salivary gland involvem ent is a hallm ark o f CMV infection (reviewed in
M ocarski et al., 1990). The virus displays a well-established tropism fo r the
salivary gland, w hich remains persistently infected fo r long periods o f tim e
follow ing infection. As a result, oral secretions represent a prim ary source o f
high-titered virus, and shedding from th is tissue is the principle means by
w hich the virus is spread w ith in a population. In the human, the parotid
salivary gland is m ost frequently involved, w ith virus replication occuring
predom inantly in the ductal epithelium (Alford and B ritt, 1990). In the mouse,
the subm axillaiy salivary gland represents the prim ary site o f MCMV
replication, w ith in the serous acinar epithelial cells (Mims and Gould, 1979).
MCMV grows to its highest tite rs in vivo in the salivary glands, and virus
produced in th is organ is significantly more viru le n t than th a t produced in any
other organ o r in cell culture (Selgrade et al., 1981).
M urine Model o f MCMV Pathogenesis
S trict species-specificity o f CMV has prevented the study o f HCMV in any
anim al model. However, infection o f mice w ith MCMV has been extensively
used as a model fo r analysis o f CMV pathogenesis (Staczek, 1990). The hum an
and m urine viruses share the follow ing characteristics: a large DNA genome of
approxim ately 230 kilobase pairs in length, analogous gene products w ith
sim ila r functions, and biologically sim ila r aspects o f pathogenesis, tissue
tropism , latency, and reactivation (M ocarski et al., 1990).
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The pathogenicity o f experim ental MCMV infections depends upon
m ultiple factors, including: the strain, age, and immune status o f the anim al;
as w ell as, the passage history o f the virus, and its dose and route o f
inoculation (reviewed in M ocarski et al., 1990). Inbred mouse strains differ in
th e ir susceptibilities to MCMV infection, w hich is partially determined by the
genes o f the m ajor histocom patibility complex (MHC), also termed H-2 genes in
mice. Mouse strains o f the H-2k haplotype, such as the C3H and CBA strains,
are more resistant to MCMV infection. In contrast, strains of the H-2d and H2b haplotypes, such as BALB/c and C57BL/6 mice, respectively, are
susceptible to MCMV disease. The resistance o f inbred mouse strains to lethal
MCMV infection is the result o f m ultiple factors determined by both H-2 and
non-H-2 genes (Mercer and Spector, 1986; Scalzo et al., 1990). For example,
the resistance o f various strains correlates well w ith the m agnitude o f their
im m une defense mechanisms, such as interferon production, n a tu ra l k ille r cell
activity, and CTL-mediated responses (reviewed in Mercer and Spector, 1986).
In addition, resistance is pa rtially conferred by the crrw-1 allele, w hich restricts
the level o f MCMV replication in the spleen, a m ajor site o f early virus
replication in vivo (Scalzo et al., 1990).
In newborn mice, relatively low doses of virus produce rapidly lethal
effects (Staczek, 1990). However, as the anim al m atures, increasingly higher
doses o f virus are necessaiy to produce disease and death. The viru s is
especially virulent for mice th a t are less than three weeks o f age. Apparently,
the fo u rth week o f life represents a period o f rapid change in MCMV
pathogenicity. MCMV infection is more severe and can be initiated w ith
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significantly lower doses o f virus in immunosuppressed mice, such as th a t
induced by to ta l body y-irradiation (Reddehase et al., 1985), or in genetically
im m unodeficient mice, such as those w ith Severe Combined Imm unodeficiency
(SCID mice) (Pollack and V irgin, 1995). For example, in BA LB/c weanling mice
a t three weeks o f age, 10s plaque-form ing u n its (PFU) o f virus w ill k ill one-half
o f the anim als inoculated (called the 50% lethal dose, or LDso) (Katzenstein et
al., 1983), whereas a SCID mouse w ill succumb to as little as two to three PFU
o f virus (Pollack and V irgin, 1995).
MCMV derived from the salivary glands o f infected mice is significantly
more virulent than th a t produced in any other organ or in cell culture (Jordan
and Takagi, 1983; Selgrade et al., 1981). For example, the LDso for salivaiygland-passaged MCMV in one-week-old suckling BALB/c mice is 30 PFU,
whereas for tissue-culture-passaged virus it is 450 PFU (Sammons and Sweet,
1989). V irulent salivaiy-gland-passaged MCMV is rapidly attenuated by a
single passage in cell culture (Osborn and Walker, 1970), however, th is
attenuation can be reversed again by passage in the mouse. The mechanism o f
th is dram atic m odification is not clear, b u t is presumed to be epigenetic.
MCMV grown in tissue culture consists prim arily o f m ulticapsid virions,
enveloped particles w hich contain from 2 to 20 capsids (Chong and Mims,
1981; Weiland et al., 1986). In contrast, salivary-gland-passaged MCMV
consists o f predom inantly single capsid enveloped virions. D uring MCMV
morphogenesis in cultured fibroblasts, assembled capsids exit the nucleus
through the nuclear pores, and form cytoplasmic inclusions consisting o f
capsid aggregates (Weiland et al., 1986). These capsid aggregates then bud into
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extended cytoplasm ic vacuoles derived from the Golgi apparatus, forming
m ulticapsid virions. On the other hand, monocapsid virions are generated by
budding a t the inner nuclear membrane. M ulticapsid virions, characteristic o f
in vitro-propagated MCMV, may be less virulent in vivo because they are fragile
and are rapidly lysed in extracellular fluids (Chong and M im s, 1981).
Alternatively, since monocapsid and m ulticapsid virions acquire their envelopes
a t different intra ce llu la r sites, the compositions o f th e ir envelopes may be quite
different, resulting in different properties during the infection process (Weiland
et al., 1986). In addition, salivary-gland-passaged MCMV is coated w ith non
neutralizing antibody, and may exhibit different adsorption properties in vivo
(Chong e ta l., 1981).
Following acute infection o f susceptible mice, the spleen and the liver
represent prim ary sites o f early virus replication, and virus tite rs in these
organs peak by the th ird day after inoculation (by either intraperitoneal or
intravenous routes) (Katzenstein et al., 1983; Yuhasz et al., 1994). Early
replication o f virus in the spleen contributes significantly to the pathogenesis o f
MCMV infection (Katzenstein et al., 1983). Splenectomized mice survive acute
MCMV infection in significantly greater numbers than mice w ith spleens, and
virus titers in the livers o f splenectomized mice are lower. A ll other organs o f
the infected anim al represent secondary sites o f virus replication, and become
infected following virus dissem ination via the blood (Stoddart et al., 1994).
In the lung, virus titers peak by the tenth or eleventh day following
infection (Yuhasz et al., 1994). Using the polymerase chain reaction on reverse
transcribed RNA samples from the lungs o f infected mice, MCMV IE1 RNA is
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present in lung tissue fo r up to 4 m onths following infection (Yuhasz et al.,
1994). In addition, a fter the acute phase o f infection, the num ber o f MCMV
genome equivalents in the lung is 10-fold higher than in any other organ
(Balthesen et al., 1993; Yuhasz et al., 1994). MCMV infection in the lung is
fundam entally different than in other organs, and a low-level chronic infection
occurs in the lung fo r a t least 4 m onths following infection. The significantly
higher level o f recurrent infection in the lungs o f irradiated mice (Balthesen et
al., 1993) is probably a ttrib u ta b le to the presence o f an active vira l infection in
th is organ. When the ho st becomes immunosuppressed, th is low-level chronic
infection increases in a ctivity and leads to clinically apparent disease. This may
explain the high incidences o f CMV-induced pneumonia in organ transplant
recipients and patients w ith AIDS (Ho, 1991; Nelson et al., 1990).
In the salivary glands o f inoculated mice, MCMV tite rs peak by thirteen
to fourteen days post-infection (Mims and Gould, 1979). The visceral organs of
infected anim als (excluding the lung) are usually cleared o f virus by four weeks
after infection, largely as the re su lt o f an aggressive CTL im m une response
(reviewed in Koszinowski et al., 1990). However, high levels o f virus continue to
be produced in the salivary glands for over one m onth, and clearance from this
organ usually occurs by the sixth or seventh week follow ing inoculation (Jonjic
et al., 1989). Remarkably, CD8+ T lymphocytes are unable to clear MCMV
from the salivary gland, instead CD4+ T cells are essential fo r the clearance o f
th is tissue (Jonjic et al., 1990). The CD4+ T lym phocytes involved belong to
the T h l subset, and the a n tivira l a ctivity o f these cells is dependent on gamma
interferon (IFN-y) (Lucin et al., 1992). However, recom binant IFN-y cannot
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replace the function o f T h l cells, indicating th a t there are other essential
factors involved in salivaiy ^land clearance.
MCMV establishes a latent infection in the spleen, kidney, lung, salivaiy
gland, bone m arrow, and blood (reviewed in M ocarski et al., 1990). Latency is
defined as the m aintainance o f vira l genomic DNA, w ith the absence o f
infectious virus production (Roizman, 1990b). In the mouse, reactivation of
latent MCMV is detected follow ing im m unosuppression. Typically,
im m unosuppression is induced by sublethal total-body irradiation (M utter et
al., 1988) or by treatm ent w ith anti-CD4 and anti-CD8 antibodies (Cardin et al.,
1993), both o f w hich cause a profound immunodepletion. In vitro, virus
reactivation is detected by explant cocultivation, in w hich organs are removed
from latently infected mice, minced, and cultured w ith permissive cells for two
to three weeks (Jordan and Pomeroy, 1991). Latency is distinguished from
persistence, or the low-level production o f infectious virus (such as th a t which
occurs in the lungs and salivary glands), by sensitive assays designed to detect
veiy low levels o f infectious MCMV in tissues of infected animals. These assays
include: PCR analysis o f reverse-transcribed RNA isolated from tissues (Yuhasz
et al., 1994), prolonged in vitro culture o f organ homogenates on permissive cell
monolayers, and inoculation o f SCID mice w ith organ homogenates (Pollack and
V irgin, 1995).
Using these methods, the organs harboring latent MCMV have been
identified, however the precise identification of the latently infected cell type(s)
rem ains obscure. In the spleen, latent MCMV is harbored w ithin the strom al
fraction, a ductal network o f sinuses supported by reticulum cells, fibroblasts,
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num erous macrophages, endothelial cells, sinusiodal-lining cells, and collagen
fibers (Pomeroy et al., 1991). In both the hum an and the mouse, monocytes
and macrophages are strongly suspected as being a reservior o f latent CMV
(Brautigam et al., 1979; Jordan and M ar, 1982; Kondo et al., 1994).
Role o f Mononuclear Cells in CMV Pathogenesis
Another hallm ark o f acute CMV infection is a leukocyte-associated
virem ia (Bale and O’Neil, 1989; Collins et al., 1994; Dankner et al., 1990;
Saltzman et al., 1988; Stoddart et al., 1994). In both humans and mice, CMV
can be recovered from peripheral blood leukocytes o f individuals w ith acute
infection, although the percentage o f cells supporting productive infection is
quite small. In CMV virem ia, monocytes are the predom inant infected leukocyte
cell type, and serve as the vehicle o f virus dissem ination during infection
(Collins et al., 1994; Stoddart et al., 1994; Taylor-Wiedeman et al., 1991). In
mice intraperitoneally inoculated w ith MCMV, th is mononuclear virem ia enables
viru s dissem ination from in itia l sites o f replication in the peritoneum, spleen,
and liver to secondary sites, such as the salivary gland and lung (Collins et al.,
1994; Stoddart et al., 1994). In these mice, virem ia peaks on the sixth day
follow ing infection, at which time it is estimated th a t MCMV DNA is present in
up to 0.1% of circulating leukocytes (Bale and O’Neil, 1989). The virem ia in
mice is actually biphasic: a prim ary virem ia occurs on day two post-infection;
these infected leukocytes, predom inantly mononuclear, disseminate MCMV to
the spleen and liver; the virus then replicates and is released from cells w ith in
these organs, resulting in a more intense secondary viremia on day six following
infection (Collins et al., 1994). Although MCMV DNA can be detected in both
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mononuclear and polym orphonuclear leukoctyes during virem ia, infectious
virus can be recovered only from the m onocuclear fractions o f circulating
leukocytes (Collins et al., 1994; Stoddart et al., 1994).
In both hum ans and mice, monocytes and macrophages have been
im plicated as the m ost likely cell type harboring latent CMV (Brautigam et al.,
1979; Kondo et al., 1994; Stoddart et al., 1994; Taylor-Wiedeman et al., 1991).
Sensitive PCR methods have reproducibly demonstrated the presence o f HCMV
DNA in peripheral blood monocytes o f healthy seropositive individuals (TaylorWiedeman et al., 1991). In vitro, hum an granulocyte-macrophage progenitors
(derived from fetal liver and bone marrow) can be latently infected w ith HCMV,
and 4 weeks later, virus can be reactivated a fter prolonged cocultivation w ith
permissive cells (Kondo et al., 1994). Reactivation o f latent HCMV in these cells
is dependent upon cellular differentiation th a t occurs during cocultivation.
HCMV permissiveness in p rim a iy monocytes derived from the blood o f
seronegative donors is also dependent on m orphological differentiation into
macrophages (Ibanez et al., 1991). C ellular activation and differentiation are
prerequisites fo r CMV expression and permissiveness in th is cell type, as well as
in others (Mocarski et al., 1990).
In m urine models o f acute infection, monocytes have been clearly shown
to contain MCMV DNA, to release infectious virus, and to be the prim ary vehicle
fo r virus dissem ination (Collins et al., 1994; Stoddart et al., 1994). In addition,
in latently infected mice, macrophages harvested from the peritoneal cavity were
found to contain MCMV DNA and to produce infectious virus upon in vitro
stim ulation w ith thioglycollate (Brautigam et al., 1979). Permissiveness o f
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m urine macrophages for MCMV infection depends upon the differentiation state
o f the cell (Lewis et al., 1990). For example, an undifferentiated macrophage
cell line (P388D1) is nonpermissive fo r MCMV replication, whereas a partially
differentiated cell line (J774A. 1) is semipermissive and a fu lly differentiated cell
line (IC-21) is permissive. MCMV infection o f J774A.1 macrophages enhances
the secretion o f biologically active IL -la and J3, indicating th a t the virus may
influence immune functions by altering the levels o f monokines (Lewis et al.,
1990). In addition, the HCMV IE1 gene enhances expression from the hum an
IL -1(3 prom oter in transient transfection experiments o f a hum an
myelomonocytic cell line (Iwamoto et al., 1990).

Collectively, interactions

between the virus and m ononuclear cells have been viewed as critica l to CMV
biology, p articularly in dissem ination and latency.
Immune Response to CMV Infection
The interaction between CMV and the host’s im m une system is complex
(reviewed in G riffiths and G rundy, 1987; Koszinowski et al., 1990; M ocarski et
al., 1990). Even in the im m unocom petent host, the virus can its e lf cause
suppression o f host responses, and can infect cells o f the im m une system
(McChesney and Oldstone, 1987; Rinaldo, 1990). Furtherm ore, eventhough the
host has evolved a n tivira l im m une defenses to control CMV replication, the
virus has evolved mechanisms o f evading these host defenses (reviewed in H ill
and Pleogh, 1994).
The most im portant non-specific host defense against MCMV infection is
the protective role o f natural k ille r (NK) cells (Bancroft et al., 1981). NK cells
are quickly activated following MCMV infection and provide the firs t line of

23

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

defense. NK activity correlates w ith the degree o f resistance, and strains o f
mice lacking NK cell function, such as homozygous beige mice, are more
susceptible to MCMV infection (Shelham et al., 1981). The adm inistration o f
anti-asialo-GMi antibody, to deplete NK cells, increases virus replication in
tissues and the severity o f infection (Bukowski et al., 1984). The adoptive
transfer o f NK cells in to suckling mice o f susceptible strains induces resistance
to MCMV infection (Bukowski et al., 1985).
Another non-specific defense against CMV, particularly in the early
stages o f infection, is the production o f IFN -a/p (Tarr et al., 1978). The
adm inistration o f antiserum against IF N -a/p reduces the resistance o f mice to
MCMV infection, and significantly increases virus titers in the blood and liver
(Grundy-Chalmer et al., 1982). MCMV-induced IFN-a/P production is pivotal
for NK cell activity, and mediates the tra ffickin g o f these activated cells to
splenic m arginal zones (Biron et al., 1995). This tra ffickin g pattern is believed
to enhance cell-mediated im m une responses by facilitating the delivery o f NKproduced cytokines (such as IFN-y) to antigen presenting cells.
In general, hum oral immune responses do not play an im po rta n t role
against prim ary CMV infection (reviewed in G riffiths and Grundy, 1987). There
is some evidence in mice th a t the passive adm inistration o f antibodies to MCMV
reduces the severity o f disease and, if given before infection, prevents disease
(Farrell and Shellam, 1991; Shanley et al., 1981). In im m unoglobulin-deficient
mice, the course and kinetics o f prim ary MCMV infection are unaffected (Jonjic
et al., 1994). However, the absence o f antibodies in these anim als results in
signficantly higher viru s tite rs in the salivary glands, spleen, and lungs
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following radiation-induced reactivation. Thus, antibodies are not needed for
the resolution o f prim ary MCMV infection, b u t significantly lim it virus
dissem ination during recurrent infection.
The cell-mediated immune response to CMV plays a central role in
controlling the infection (Koszinowski et al., 1990). Individuals w ith deficiencies
in th is arm o f the immune system are a t high risk o f CMV disease (Ho, 1991;
Nelson et al., 1990). In HCMV infection, the CTL response correlates w ith
successful resolution o f infection in bone-m arrow -transplant recipients
(Quinnan et al., 1982). The im m unodom inant CTL epitopes o f HCMV are
directed predom inantly against the pp65 and p p l5 0 m atrix-tegum ent proteins
(Greenberg, 1995), although there are significant CTL responses to the IE72 and
gB proteins as well (Boiysiewicz et al., 1988). Adoptive im m unotherapy in
bone-m arrow-transplant patients using HCMV-specific syngeneic CTLs
elim inates HCMV disease (Greenberg, 1995). In 13 patients receiving th is
treatm ent, none showed HCMV virem ia or any other symptoms o f disease.
In a m urine model, the adoptive transfer o f MCMV-specific CTL
completely protects immunosuppressed mice from a lethal challenge w ith
MCMV, and is therapeutically effective in anim als w ith established infections
(Reddehase et al., 1985 and 1987). In BALB/c mice, IE antigens dominate the
CTL response to MCMV infection (Reddehase et al., 1987), particularly the IE1
protein pp89 (Volkmer et al., 1987). Remarkably, a single nonapeptide from
pp89 is the only epitope o f th is protein th a t is recognized by BALB/c CTLs (Del
Val et al., 1988). A recom binant vaccinia virus expressing th is single T-cell
epitope protects mice against lethal MCMV challenge (Del Val et al., 1991).
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In infected mice, th is aggressive CTL response begins a t seven to ten
days follow ing infection, and is responsible fo r clearing viru s from a ll tissues of
the anim al, except the salivaiy gland (Lucin et al., 1992). Persistent, high-level
growth o f MCMV in the salivaiy glands is the result o f the escape o f acinar
glandular epithelial cells from CTL recognition (Jonjic et al., 1989). Apparently,
th is is the only cell type th a t requires the function o f T helper lymphocytes, in
addition to CTL, to clear persistent MCMV infection (Lucin et al., 1992). Mice
depleted o f CD4+ T lymphocytes develop a chronic MCMV infection in the
acinar glandular epithelial cells o f the salivaiy glands (Jonjic et al., 1989).
Surprisingly, mice depleted o f CD8+ T lymphocytes elim inate MCMV w ith
kinetics sim ilar to th a t o f norm al mice (Jonjic et al., 1990). In these mice, the
CD4 subset gains protective functions and fu lly compensates for the CD 8
deficiency.
Recovery from p rim aiy CMV infection requires the function o f T
lymphocytes. These T cells lim it virus replication not only by direct cytolytic
a ctivity against infected cells, b u t also by secreting cytokines a t the site o f
infection (Doherty et al., 1992). In B ALB/c mice, neutralization o f IFN-y
abrogated the a b ility o f the T h l subset o f CD4+ T lymphocytes to clear MCMV
from the salivary glands (Lucin et al., 1992). Neutralization o f TNF-a also
abolished virus clearance from the salivaiy glands, as w ell as clearance from
other target organs in CD8-depleted mice (Pavic et al., 1993). In addition, IFN-y
and TNF-a act synergistically to drastically in h ib it MCMV replication by
interfering w ith MCMV morphogenesis during the late phase o f the virus
replication cycle (Lucin et al., 1994). These two cytokines also play c ritic a l roles
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in activating macrophages during MCMV infection in both im m unocom petent
and im m unodeficient (SCID) mice (Heise and V irgin, 1995).
CMV is a persistent virus th a t rem ains associated w ith its host fo r life
follow ing p rim a iy infection. To accom plish persistence, CMV has evolved
strategies to escape im m une detection, and thereby coexist in the presence o f
specific host im m une defenses. These im m une evasion strategies include: a
virus-induced im m unosuppression (McChesney and Oldstone, 1987; Rinaldo,
1990), and an in h ib itio n o f CTL recognition (Campbell et al., 1989 and 1992).
CMV, like the other herpesviruses, causes im m une suppression (Rinaldo,
1990; McChesney and Oldstone, 1987). The virus can infect cells o f the
im m une system, namely lymphocytes (Schrier et al., 1985) and monocytes
(Brautigam et al., 1979; Collins et al., 1994; Ibanez et al., 1991; Kondo et al.,
1994; Stoddart et al., 1994). Infection o f these cells, whether abortive o r
productive, im pairs th e ir function and leads to generalized im m unosuppression
(Rice et al., 1984; Schrier et al., 1986a and 1986b). For example, infection o f
peripheral blood m ononuclear cells w ith HCMV results in depressed
proliferative responses o f T lymphocytes to antigen and to mitogen
(phytohem agglutinin), in suppressed NK cell activity, in depressed antibodydependent cell-mediated cytotoxicity, reduced interferon induction by mitogens,
and in suppressed class I-restricted CTL activity' (Schrier et al., 1984, 1986a,
1986b). The IE1 and IE2 proteins o f HCMV up-regulate the transform ing
growth fa cto r-p i (TGF-(31) prom oter (Michelson et al., 1994). This induction o f
TG F-pi may contribute to HCMV-induced im m unosuppression, since th is
cytokine can have profound negative effects on immune responses.
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Acute infection o f SV40-immunized mice w ith MCMV prevents the
activation o f SV40-specific CTL precursors (Campbell et al., 1989). MCMV
infection o f mice also significantly suppresses the prim ing o f T helper
lymphocytes (Slater et al., 1991). These in h ib ito ry effects o f MCMV infection on
T helper and CTL functions are independent, indicating th a t the virus induces a
defect in antigen processing or presentation (Slater et al., 1991). In vitro, MCMV
infection o f SV40-transform ed fibroblasts and macrophages prevents the
presentation o f SV40 large T antigen to SV40-specific CTLs (Campbell et al.,
1992). SV40-transform ed target cells th a t are infected w ith MCMV are not
recognized by class I-restricted, SV40-specific CTL clones. This in h ib itio n in
the presentation o f T antigen requires MCMV early gene expression.
Interestingly, the presentation o f the im m unodom inant pp89 epitope to specific
CTLs in intro is also inhibited during the early phase o f MCMV infection (Del Val
e ta l., 1989).
CTLs recognize short peptides, derived from vira l proteins synthesized
inside the infected cell, and presented a t the cell surface by MHC class I
molecules (Townsend et al., 1989). This process o f antigen presentation
requires th a t the class I heavy chain assemble w ith the vira l peptide and P2 m icroglobulin in the endoplasmic reticulum /ds-G olgi to form a stable
trim olecular complex, w hich is then exported to the surface of the infected cell
(Townsend et al., 1989 and 1990). CMV, as w ell as a number o f other viruses,
in h ib its CTL recognition by down-regulating the expression of MHC class I
molecules in infected cells (Barnes and Grundy, 1992; Beersma et al., 1993;
Campbell et al., 1992; Del Val et al., 1992; W arren et al., 1994; Yamashita et
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al., 1993), suggesting th a t th is is a common mechanism for immune evasion
among infectious viruses.
In HCMV infection, m arked reduction in the surface expression o f class I
molecules is not the result o f a reduction in the synthesis of either the heavy or
lig h t chain (Yamashita et al., 1993). Eventhough pulse-chase experiments
show a drastic reduction in the steady state levels o f hum an class I heavy
chains, th is effect is not due to a reduced rate o f synthesis, b u t rather to the
accelerated degradation o f these proteins (Beersma et al., 1993). These effects
o f HCMV are insensitive to the effects o f phosphonoacetic acid, indicating the
involvement o f IE or E vira l gene products. In vitro, HCMV infection im pairs
class I assembly (Warren et al., 1994). Further pulse-chase analyses show th a t
class I complexes are assembled in infected cells, b u t are unstable and are
rapidly degraded. Im portantly, the decreased surface expression o f class I
molecules in HCMV-infected cells is accompanied by resistance to CTL lysis
(Warren et al., 1994). IFN-y and TNF-a counteract the HCMV-induced
reduction in class I expression by greatly increasing class I synthesis and
assembly (Hengel et al., 1995). Although these cytokines can compensate for
the negative effect on antigen presentation, HCMV-induced interference w ith
class I form ation remains active. Therefore, th is cytokine effect does not act
through a n tivira l activities, b u t instead is associated w ith the induction o f class
I genes o f the host.
In MCMV-infected cells, early viral gene expression drastically reduces
the levels o f H-2K and H-2D molecules on the surface o f infected fibroblasts
(Campbell et al., 1992). Treatm ent w ith IFN-y partially restores class I
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expression, b u t does n o t overcome the block in antigen presentation. Pulsechase experiments show th a t MCMV early gene expression drastically reduces
the synthesis o f class I molecules in infected cells (Campbell and Slater, 1994).
MCMV infection prevents m aturation o f class I heavy chains to th e ir fu lly
glycosylated form s, and in h ib its their transport from the ER/cis-Golgi to the cell
surface (Campbell and Slater, 1994; Del Val et al., 1992). Completely
assembled trim olecular class I complexes form , b u t are retained before entering
the medial-Golgi com partm ent (Del Val et al., 1992). MCMV infection not only
in h ib its the synthesis and transport o f class I heavy chains, b u t it also reduces
the steady-state levels o f class I mRNA (Campbell et al., 1995), indicating th a t
the in h ib itio n in class I expression may be due, in part, to the reduced
transcription o f these genes. By in h ib itin g the expression of MHC class I
molecules, CMV lim its the num ber o f recognition molecules on the surface o f
infected cells, and th u s enables them to escape CTL recognition and persist in
the host.
Nonessential V ira l Genes
CMV biology is complex, and understanding the interactions between the
virus and its host are necessaiy to unravel the mechanisms of viral
pathogenesis. The fa ct th a t CMV infections are persistent and remain largely
asymptomatic in the norm al host are tributes to the ways in which the virus
has evolved to live in equilibrium w ith its host. The v ira l genome is estimated to
encode over 200 genes (Chee et al., 1990; Rawlinson et al., 1993), w hich serves
to reinforce its com plicated biology. W ith such a large num ber o f vira l genes,
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any one o f them may be expected to play a subtle role in the biology o f CMV
infection.
W ith numerous viruses, the generation and analysis o f m utants have
proven to be invaluable in determ ining the function o f specific vira l genes. The
construction o f n u ll m utants is useful in distinguishing those genes im portant
fo r v ira l growth from those more im portant in pathogenesis. Using n u ll
m utants, vira l genes can be operationally divided into two categories:
1) essential genes, or those required fo r virus replication in tissue culture; and
2) nonessential genes, o r those th a t are not required fo r virus replication in
tissue culture (Mocarski et al., 1990). Any nonessential gene, encoding a
protein w hich does not influence virus growth in cell culture, m ight instead be
expected to influence v iru s /h o st interactions in vivo. Because the selective
pressures w hich exist during propagation in a living host are absent during
propagation in cultured cells, it would make sense th a t genes w hich encode
pathogenic factors are nonessential. Nonessential vira l genes probably
influence various aspects o f pathogenesis in vivo, such as virulence,
persistence, latency, im m une evasion, tissue tropism , virus dissem ination, and
transm ission. Furtherm ore, these nonessential genes are m aintained in natural
isolates o f viruses (Gooding, 1992), im plying th a t they m ust be o f substantial
value to the virus in vivo. It seems unlikely th a t viruses would conserve any
unnecessary genes if they did not serve some useful purpose in an in ta ct
anim al host.
There are num erous examples o f nonessential vira l genes th a t play a
critica l role in pathogenesis in vivo, eventhough they are dispensable fo r virus
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replication in vitro (listed in Table 1). For example, the E3 region o f adenovirus
2, which encodes a 19-kd protein th a t prevents MHC class I transport to the
cell surface (Burgert et al., 1985 and 1987) and three additional proteins th a t
in h ib it lysis o f infected cells by TNF (Gooding et al., 1988 and 1991), are
nonessential. In a rodent model o f adenovirus pneumonia, the deletion o f the
E3 region from the vira l genome results in a viru s w ith m arkedly increased
pathogenicity in vivo (Ginsberg et al., 1989). In contrast, the deletion o f
nonessential poxvirus genes encoding in h ib ito rs fo r TNF (Smith et al., 1991) or
complement fixation (Kotwal et al., 1990), re su lt in recom binant viruses w ith
severely reduced pathogenicity in infected rabbits (Isaacs et al., 1992; Upton et
al., 1991). Several HSV-1 m utants m issing nonessential genes located in the Us
and inverted repeat sequences o f the vira l genome are avirulent in mice (Chou
et al., 1990; Meignier et al., 1988). A nonessential HSV-1 IE protein, designated
ICP47, blocks the transport o f MHC class I molecules to the cell surface (York et
al., 1994), possibly by in h ib itin g the function o f the transporter associated w ith
antigen processing (Johnson et al., 1995). In infected mice, an HSV-1 m utant
m issing the ICP47 gene displays greatly attenuated growth and pathogenicity
(Johnson et al., 1995).
In HCMV, a cluster o f contiguous genes, the IRS1 and US1 through
US 13 genes, o f the AD 169 strain are nonessential for virus replication in cell
culture (Jones et al., 1991 and 1992). Two loci w ith in th is nonessential region,
namely US11 and a gene w ith in US2-5, are responsible fo r the reduction in
MHC class I expression observed in HCMV-infected cells (Jones et al.,1995),
and are presumed to function in im m une evasion and virus persistence.
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However, because there is no experimental anim al model for HCMV studies, the
role o f these nonessential genes in pathogenesis in vivo is not clear.
MCMV M utants
To date, num erous MCMV m utants have been generated (Boname and
Chantler, 1992; Cardin et al., 1993; Kum ura et al., 1990; Manning et al., 1988
and 1992; Sammons and Sweet, 1989; Sandford and Bum s, 1988; Tonari and
M inam ishim a, 1983; Vieira et al., 1994). Some o f these represent temperaturesensitive (ts) m utants (Sammons and Sweet, 1989; Sandford and Bum s, 1988;
Tonari and M inam ishim a, 1983), w hich were generated in a random fashion by
exposing wild-type (WT) MCMV to u ltra -vio let lig h t or to chemical mutagens.
Due to th e ir nature, these viruses are conditionally lethal m utants in which
alterations lie in genes essential for virus replication in vitro, thus their in a b ility
to grow in cultured cells at nonpermissive temperatures. A few o f these ts
m utants exhibit reduced in irivo growth and virulence, however, the defects
responsible for th is phenotyoe have not been fu lly characterized (Kumura et al.,
1990). Because unselected m utations other than temperature sensitivity can
also exist in these virus m utants, the task o f characterization is even more
d ifficu lt.
An alternative method to random -site mutagenesis, used to generate ts
m utants, is site-directed mutagenesis using a selectable m arker gene. This
method offers the advantages th a t m utations can be targeted to selected regions
o f the vira l genome, and th a t they lie in nonessential genes, or those genes
believed to influence the interactions between the virus and the host. Using
site-directed insertion and deletion mutagenesis, several MCMV genes have
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been identified as being nonessential. In 1988, M anning and Mocarski
successfully generated recom binant MCMV by using the E. coli LacZ gene as a
m arker for site-directed insertion into the IE2 gene. This recom binant was the
firs t defined genetic m utation in a specific MCMV gene, and demonstrated th a t
the IE2 gene is nonessential fo r growth in cultured m urine fibroblasts.
Subsequent in vivo experiments designed to evaluate the function o f IE2 in
replication, tissue tropism , and latency have failed to identify a role for this
gene in these aspects o f vira l pathogenesis (Cardin et al., 1993). Since 1988,
th is group of investigators has constructed several other recom binant viruses
canying insertions disrupting each o f the seven open reading frames encoded
w ith in the Hind III-J region o f the MCMV genome (Vieira et al., 1994). A ll o f the
genes encoded w ith in the Hind III-J fragm ent are expressed a t early times
during the viral replication cycle, except one, w hich is expressed at late times.
To date, there are published reports of in vivo studies on only those m utants
disrupting two o f these seven genes, the gene expressed a t late times and a gene
denoted sggl (for salivary gland growth genel). Like the IE2 gene, a function
for the late gene has not yet been identified in the infected mouse (Cardin et al.,
1993). MCMV m utants disrupted in this late gene show only a slight reduction
in salivary gland tite rs. However, th is phenotype is observed w ith a ll other
LacZ-tagged viruses, and appears to be independent o f the insertion site
(Lagenaur et al., 1994; M ocarski et al., 1990).
The sggl m utants display drastically reduced growth in the salivary
glands, while growth in other organs is not significantly affected (Manning et
al., 1992). This same phenotype is observed w ith another spontaneous MCMV
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m utant, called the Vancouver strain, w hich was isolated during the in vitro
passaging o f the parental virus (Boname et al., 1992). This m utant carries a
large deletion w ith in the H ind III-E fragm ent and an insertion w ith in the Hind
III-D region o f the vira l genome. Therefore, these findings suggest th a t other
vira l genes, in addition to the s g g l gene, influence MCMV replication in the
salivaiy glands o f infected mice. Another gene located in the Hind III-J
fragm ent encodes a receptor fo r the Fc dom ain o f m urine im m unoglobulin G
molecules, and is denoted f c r l (for Fc receptor 1) (Thale et al., 1994). W ith the
exceptions o f the s g g l and f c r l genes, the functions o f the rem aining genes
encoded w ith in the H ind III-J region o f the MCMV genome are not known.
A t the present tim e, the entire MCMV sequence has been determined
(Rawlinson et al., 1993), although it has not been published. In spite o f this,
the locations and functions o f only a relatively few num ber o f the estimated 200
genes o f th is virus have been characterized. Most o f these represent essential
genes, and include those encoding the IE1 and IE3 proteins, the DNA
polymerase and MDBP, and envelope glycoproteins B and H. The nonessential
genes identified to date include the IE2, s g g l, and f c r l genes. The functions of
these nonessential genes during infection is not completely understood.
Clearly, additional m utants are needed in order to identify those MCMV
sequeces involved in pathogenesis in vivo.
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n . SPECIFIC OBJECTIVES
The purpose o f th is study was to identify MCMV genes involved in
pathogenesis in xavo. O ur approach to identifying these genes involved
constructing MCMV m utants, and then analyzing these m utants in vitro and in
vivo. Recombinant viruses (RV) were constructed by inserting the E. coli (3-

glucuronidase (P-glu) m arker gene into selected regions o f the vira l genome by
homologous recom bination. RV generated by th is method w ill be m utated in
nonessential genes, those predicted to im pact on the interaction o f MCMV w ith
the host animal. Therefore, th is study provides the ideal opportunity in which
to examine the effects o f MCMV genes th a t are dispensable for growth in vitro on
the pathogenesis o f the virus in vivo. Characterizing these genes w ill provide
im portant inform ation about the m olecular mechanisms o f MCMV
pathogenesis.
The specific objectives o f th is project were to:
1) C onstruct recom binant MCMV using the B-glu gene as a m arker gene. Our
basic strategy involved inserting the P-glu gene into selected MCMV genomic
clones. The resulting clones were linearized and cotransfected w ith infectious
MCMV DNA into NIH3T3 fibroblasts. Following homologous recom bination of
the flanking sequences, plaques containing RV were selected by a blue
phenotype after overlaying the transfected cells w ith agarose containing the
chromogenic substrate fo r the p-glu enzyme.
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2) Analyze recom binant MCMV in vitro to identify viral sequences involved in
virus growth and MHC class I expression. MCMV recombinants were tested for
th e ir effects on:
a) Growth in cell lines o f fibroblast and myeloid origin.
b) IE, E, and L gene expression in these cell lines.
c) MHC class I expression in a fibroblast cell line.
3) Analyze recom binant MCMV in a m urine model to identify viral genes
involved in pathogenesis in vivo. MCMV m utants were examined fo r th e ir
effects on growth in the salivaiy glands, spleen, liver, and lungs o f infected
mice.
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m . MATERIALS AND METHODS
Cells
NIH3T3 cells, a contact-inhibited m urine fibroblast cell line (from
American Type C ulture Collection [ATCC], CRL1658, Rockville, MD), were
propagated in Dulbecco’s modified essential media (DMEM, Mediatech,
Herndon, VA) supplemented w ith 10% heat-inactivated bovine c a lf serum
(Hyclone Laboratories, Logan, UT) and 1% L-glutam ine (Gibco/BRL, Grand
Island, NY). WT-19 cells, derived from C57BL/6 mouse prim aiy kidney
fibroblasts after transform ation w ith SV40 large T antigen (Tevethia et al.,
1980), were grown in DMEM containing 10% heat-inactivated fetal c a lf serum
(Gibco/BRL) and 1% L-glutam ine. These cells were kin d ly provided by Dr.
Satvir Tevethia, Pennsylvania State U niversity School o f Medicine (Hershey, PA).
IC -2 1 cells, an SV40-transformed peritoneal macrophage cell line from
C57BL/6 mice (Mauel and Defendi, 1971), were obtained from ATCC and were
propagated in RPMI media (Mediatech) supplemented w ith 10% heat-inactivated
fetal ca lf serum and 1% L-glutam ine. Prim aiy fibroblasts, derived from the
embryos o f tim ed-pregnant BALB/c.ByJ mice (Jackson Laboratories, Bar
Harbor, MN) on day 19 o f gestation, were cultured in DMEM containing 20%
heat-inactivated fetal ca lf serum, 1% L-glutamine, and 50 pg/m l o f gentamicin
sulfate (Sigma Chemical Co., St. Louis, MO). Prim aiy em biyo fibroblasts were
used before reaching th e ir fifth passage in tissue culture.
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V irus
The parental WT MCMV used in these studies was o f the Sm ith strain
(from ATCC). Stocks o f virus, WT as well as m utant, were prepared in and
titered on NIH3T3 fibroblasts, as previously described (Campbell et al., 1989).
Mice
Male 20-day-old weanling BALB/c.ByJ mice were purchased from
Jackson Laboratories, and were housed in m icroisolator cages w ith sterile food,
water, and bedding. Mice were injected intraperitoneally (using a 27-gauge
needle) w ith tissue-culture-passaged virus (1.5 X 10s PFU in 0.1 m l phosphatebuffered saline) a t 21 days o f age. Anim als were sacrificed, a t indicated times
post-inoculation, by cervical dislocation, a method accepted by the Panel on
Euthanasia o f the American Veterinary Medical Association.
Restriction endonuclease mapping
The sites fo r various restriction endonucleases were identified w ith in the
MCMV Hind III-F , -J, and -I genomic plasm id clones by standard methods
(Maniatis et al., 1987). A ll enzymes were purchased from Promega (Madison,
WI), and digestions were conducted w ith buffers supplied by the m anufacturer,
according to the provided instructions.
Plasmid constructions
Plasmid cloning was conducted by standard methods (M aniatis et al.,
1987), and restriction endonuclease digestions were done according to
m anufacturer’s (Promega) suggestions.
A genomic lib ra ry o f MCMV DNA (Sm ith strain) was constructed by
digesting the vira l genomic DNA w ith H ind III, and then cloning these fragments
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into the Hind III site o f the plasm id vector pGEM-4Z (Promega). The H ind III-F ,
-I, -J, and -L genomic clones were utilized in th is study.
The plasm id designated p e lp -g lu (shown in Fig.4A) was constructed in
the pGEM-7Z vector (Promega), and contains the p-glu reporter gene under the
control o f the MCMV early region 1 (el) prom oter. This e l/p -g lu cassette
contains 2.2 kb o f the p-glu gene (derived by digestion o f plasm id pgHBglOpA
[kindly provided by Dr. Thomas Jones, Am erican Cyanamid Co., Pearl River,
NY] w ith Nco I and Sst I), coupled to 0.2 kb o f the e l promoter. The e l
prom oter was derived from the 5.5 kb Pst I fragm ent o f the MCMV Hind III-F
genomic clone, w hich contains the entire e l transcription u n it (Buhler et al.,
1990). The prom oter consists o f an Sst I to Nco I fragment, containing the firs t
200 nucleotides upstream o f the sta rt site o f transcription (which is located a t
the Nco I site). The entire 2.4 kb e l/P -g lu cassette can be removed from p e ip glu by digestion w ith Sst I.
A recom bination plasm id o f an insertion m utant o f the MCMV Hind III-J
genomic clone, designated p jp g lu -5 (shown in Fig. 4C), was constructed by
inserting the e l/p -g lu cassette into the second Sst I site. The H ind III-J
plasm id was p a rtia lly digested w ith Sst I, and linearized molecules (m igrating at
10.9 kb [8.1 kb o f MCMV Hind III-J sequences and 2.8 kb o f pGEM-4Z
sequences]) were isolated from a 5% aciylam ide gel. These molecules were
treated w ith phosphatase, and then ligated to the gel-purified 2.4 kb e l/p -g lu
fragm ent derived from p e l/p -g lu by Sst I digestion. The resulting clones were
screened fo r the location o f insertion o f the cassette, and only one o f the two
possible insertions was generated.
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Recombination plasm ids o f deletion m utants o f the MCMV H ind III-J and
-I genomic clones, designated p jp g lu -6 , pJiPglu-7, and pJiPglu-9 (shown in Fig.
4C), were constructed by deleting selected genomic sequences and replacing
them w ith the e l/P -g lu cassette. To facilitate in the construction o f these
deletion m utants, a plasm id (called p 3 .4 jp g lu, shown in Fig. 4B) was made th a t
contained only the firs t 3.4 kb o f H ind III-J coupled to the e l/P -g lu cassette.
This plasm id was constructed by completely digesting MCMV H ind III-J w ith
Sst I, isolating the large 6.3 kb band (consisting o f vector sequences and the
firs t 3.4 kb o f Hind III-J sequences) from an aciylam ide gel, and inserting the
e l/p -g lu cassette in to the Sst I site. Plasmid p 3 .4 jp g lu was then partially
digested w ith Sst I, and linearized molecules (m igrating a t 8.7 kb) were gel
purified and ligated to other various Sst I-digested fragments from Hind III-J or
-I (also gel-purified). To construct p jp g lu -6 , the 1.9 kb Sst I fragm ent o f Hind
III-J was cloned behind the cassette, thereby deleting 2.8 kb o f H ind III-J
genomic sequences. To create pJIpglu-7, the m iddle 3.0 kb Sst I fragm ent o f
H ind III-I was cloned behind the cassette, resulting in the deletion o f 7.7 kb of
genomic sequences from the Hind III-J and -I regions. To construct pJiPglu-9,
the 3.7 kb Sst I fragm ent of Hind III-I was cloned behind the cassette, deleting
10.7 kb from Hind III-J and -I.
Isolation o f MCMV DNA
Intact, infectious MCMV DNA was prepared from virions purified from a
WT virus stock by sorbitol cushion density gradient centrifugation. Five
m illilite rs (ml) o f a 20% sorbitol solution (made in 50 mM Tris-HCl [pH 7.5], 1
mM MgCfe) was added to the bottom o f polypropylene centrifugation tubes (30

41

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

cc volume, Beckman Instrum ents, Fullerton, CA). Then, 15 m l o f virus stock
was very slowly layered on top o f th is sorbitol cushion, being careful not to m ix
the interface. The virions were pelleted by centrifugation a t 27,000 x g for 45
m inutes (Beckman Instrum ents, centrifuge model JA1000). The liq u id from
each tube was then removed by aspiration, and the pellet was resuspended in
1.0 m l o f lysis buffer (20 mM Tris-HC l [pH 7.5], 100 mM NaCl, 10 mM EDTA,
0.1% SDS, 1% N-lauroylsarcosine, and 100 pg/m l proteinase K) overnight at
room tem perature w ith gentle shaking. The virus lysates from 12 tubes were
pooled, extracted twice w ith phenol (saturated w ith TE buffer [10 mMTris-HCl,
pH 7.5, 1 mM EDTA]), once w ith chloroform (25 parts chloroform to 1 part
isoam yl alcohol), and precipitated in 70% ethanol overnight at -20° C. The DNA
was pelleted by centrifugation, washed twice w ith 70% ethanol, briefly dried,
and resuspended overnight in 5 m l o f TE buffer a t 4°C. The MCMV DNA was
quantitated on a spectrophotometer (Spectronic 1001 Plus, M ilton Roy Co.,
Rochester, NY) a t 260 nm, aliquoted into sterile eppendorf tubes, and stored at
-80°C.
Construction of recom binant MCMV
Recombinant MCMV was generated by cotransfecting infectious MCMV
DNA and linearized plasm id DNA into NIH3T3 cells, where the DNAs undergo
homologous recom bination to create a m u ta n t viral genome. Plasmid DNAs
were prepared for cotransfection by digestion w ith H ind III, extraction w ith
phenol and chloroform , ethanol precipitation, and resuspension in sterile
distilled water. The DNAs were cotransfected into NIH3T3 cells using a
m odified calcium phosphate precipitation technique described in C urrent
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Protocols in M olecular Biology (1990 edition, section I, u n it 9.1, supplement
14). A total o f 7 jag o f DNA (3 jag o f MCMV DNA and 4 |ag o f linearized plasm id
DNA) was transfected into 5 X 105 cells in suspension. The DNAs were added to
500 pi o f sterile distilled water in a sterile eppendorf tube, 50 pi o f a 2.5 M CaCb
solution was added, and the solution was gently mixed. This DNA/CaCb
solution was then added drop-by-drop to 500 pi o f 2X hepes-buffered saline
38.4 mM hepes, 274 mM NaCl, 10 mM KC1, 1.6 mM Na2 HPO«, 0.2% dextrose,
pH 7.05) in a sterile 15 m l conical tube. The DNA precipitate was allowed to
form a t room tem perature fo r 20 m inutes. Then 9 m l o f a cell suspension
(containing 5 X 10s cells in NIH3T3 culture media) was added to the tube
containing the DNA precipitate. The entire m ixture was placed into a 100-mm
tissue culture plate and incubated at 37°C. To increase cellular uptake o f DNA,
the cells were shocked w ith a 20% dim ethyl sulfoxide solution in NIH3T3
culture media (2 m l for 3 minutes) a t five hours post-transfection. After
washing the cell monolayers three tim es w ith phosphate-buffered saline (pH
7.4), culture media was added to the plate. When the firs t signs o f cytopathic
effect were visible, usually between 6 to 8 days post-transfection, the monolayer
was overlayed w ith 0.5% agarose. Three o r four days later, when the viral
plaques reached a large size, a second agarose overlay containing 150 pg /m l o f
the X-glu substrate (5-brom o-4-chloro-3-indolyl-p-D-glucuronide, Biosynth Inc.,
Zurich, Switzerland) was applied to the cells. The X-glu diffused through the
firs t agarose overlay to reach any plaques containing RV expressing the P-glu
gene. These RV-containing plaques became blue in color w ith in 24 hours o f the
second overlay.
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P urification o f recom binant MCMV
To isolate a pure population o f RV, blue plaques on p rim a iy transfection
plates were picked as agar plugs, and underwent a t least five rounds o f plaque
purification. Blue plaques were picked using sterile Pasteur pipettes, the agar
plug was placed into 1 m l o f culture media (in a sterile 5 m l snap-cap tube), and
pipetted up and down several tim es to break apart the plug and facilitate virus
release from the agar. This 1 m l inoculum was then used to infect a fresh
culture plate o f subconfluent NIH3T3 cells. After viru s adsorption fo r 1 hour at
37°C, the inoculum was removed and the monolayer was overlayed w ith 0.5%
agarose. Four o r five days later, when virus plaques were large in size and welldeveloped, the second overlay containing X-glu was added. The following day,
well-isolated blue plaques were picked, and the cycle was repeated. A t the
fo u rth round o f purification, only one-tenth o f the 1 m l inoculum was used to
infect a fresh plate o f cells. This was done to ensure th a t a well-isolated blue
plaque could be picked w ith o u t significant chances o f contam ination w ith virus
from any neighboring plaques. A t the fifth round, a fin a l blue plaque was
placed into 5 m l o f media. Four m l o f th is inoculum was used to infect a flask o f
cells for the purpose o f preparing a high-titered stock o f RV. The rem aining 1
m l was used to infect another plate o f cells fo r the purpose o f isolating infected
cell DNA for Southern b lo t analysis.
Southern blot analysis
DNA was prepared from mock-, WT-, or RV-infected NIH3T3 cells as
previously described (Stenberg et al., 1989), and quantitated a t 260 nm. Mock
infections utilized cell cu ltu re supernatants from noninfected NIH3T3 cells, and
served as a negative control. Southern blots were conducted as described by
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M aniatis and coworkers (1987). Infected cell DNAs were digested w ith Hind III
and Bgl II, or w ith Bgl II alone, and after digestion, 2 pg o f each sample was
loaded into the wells o f a 0.8% agarose gel. The DNA fragm ents were separated
by electrophoresis overnight a t 22 volts. The following day, the gels were
stained w ith ethidium bromide, and were photographed alongside a fluorescent
ruler. To facilitate the transfer o f DNA fragments, the gels were soaked in 0.25
M HC1 fo r 10 m inutes, followed by incubations in denaturing solution fo r one
hour and neutralizing solution for another hour. DNA fragm ents were
transferred to positively-charged nylon membranes (Boehringer Mannheim,
Indianapolis, IN) overnight in 20X SSC. The following day, the DNA was fixed to
the membrane by UV cross-linking (150 J) and baking a t 80°C for one hour.
The Boehringer M annheim Genius System was used to hybridize the
membranes to probes o f MCMV Hind III-J , -I, or the P-glu gene. This system
utilizes probes labeled by random prim ing w ith digoxigenin (DIG), and an
antibody to DIG fo r chem ilum inescent detection. The membranes were exposed
to XAR5 film (Fuji) w ith intensifying screens a t room tem perature for 15 to 60
seconds.
The MCMV H ind III-J and -I probes were made from gel-purified
fragments (8.1 kb and 9.7 kb, respectively) following H ind III digestion o f these
genomic clones. The p-glu probe was made from the gel-purified 2.2 kb Nco I to
Sst I fragm ent o f plasm id p e l /P-glu.
In vitro growth o f MCMV m utants

Approxim ately 1 X 106 cells were seeded into duplicate tissue culture
flasks (25 cm2) in 5 m l o f culture media. The following day, the cells were
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infected a t a m u ltip lic ity o f infection (moi) o f 0.1 PFU per cell w ith either WT or
m utant MCMV (for m ulti-step growth curves) in a one m l inoculum volume.
After virus adsorption fo r one hour a t 37°C, the inoculum was removed, the cell
monolayer was washed twice w ith warmed phosphate-buffered saline, and 5 m l
o f fresh culture media was added to each flask. Flasks were incubated at 37°C
u n til the indicated day post-infection (the 0 tim e point was harvested
immediately). To harvest virus, the flasks were frozen fla t at -100°C, thawed at
37°C, and the suspension was transferred to a 50 m l conical tube and
sonicated fo r 30 seconds. Following centrifugation to remove cellular debris,
to ta l infectious virus in the supernatants was quantitated by standard plaque
assay on NIH3T3 cells. For one-step growth curves, the cultures were infected
a t an m oi o f 5 PFU per cell.
Northern blot analysis
Approxim ately 2 X 106 cells were seeded into 100-mm tissue culture
plates the day before infection. The cells were mock-infected, or infected w ith
WT or m utant MCMV a t an m oi o f 4 PFU per cell. Following virus adsorption at
37°C for one hour, the inoculum was removed, the cell monolayer was washed
w ith warmed phosphate-buffered saline, and 10 m l o f culture media was added.
For immediate early RNA isolation, to ta l RNA was harvested from cultures a t 3
hours post-infection. For early RNA isolation, phosphonoacetic acid was added
to the culture media a t a concentration o f 250 pg per m l at the time o f virus
infection for a duration o f 24 hours. For late RNA isolation, total RNA was
harvested from cultures a t 24 hours after infection. The Qiagen RNeasy K it for
total RNA isolation (Qiagen, Chatsworth, CA) was used to harvest RNA from
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infected cells, as described by m anufacturer’s instructions. Northern blots were
conducted as described by M aniatis and coworkers (1987). RNA samples were
quantitated a t 260 nm, and 5 (ig o f each sample was loaded into the wells o f
1.5% agarose/6.6% formaldehyde gels and electrophoresed overnight a t 22
volts. The following day, the gels were rinsed three tim es in sterile distilled
water (10 m inutes per wash), and transferred to positively-charged nylon
membranes overnight in 20X SSC. After transfer, the membranes were UV
cross-linked (150 J), and baked a t 80°C fo r 30 m inutes. The Boehringer
Mannheim Genius System was used to hybridize the membranes to probes o f
H ind III-L (containing the IE1 and IE2 genes), e l, o r gB.
The Hind III-L probe was made from the gel-purified 7.3 kb fragm ent
following Hind III digestion o f th is MCMV genomic clone. The e l probe was
made from the gel-purified 1.4 kb Nco I to Eco RI fragm ent derived from the 5.5
kb Pst I fragm ent o f MCMV Hind III-F. The gB probe was made from the gelpurified 3.5 kb Bam HI to Pvu II fragm ent derived from plasm id pLig3.5 (kindly
provided by Dr. U lrich Koszinowski, University o f Heidelberg, Heidelberg,
Germany).
The 2.75 kb IE 1 RNA transcript, the 2.60 kb e l transcript, and the 3.30
kb gB transcript were quantitatively estimated by densitom etric scanning o f
autoradiographs. The Sun UNIX-SPARC station 5 densitometer (Mountain
View, CA), equipped w ith an OmniMedia 12cx-XRS scanner (Torrance, CA), was
used to scan and analyze autoradiographs. The Bio-Image (Ann Arbor, MI)
whole band analyzer program was used to quantitate the integrated intensities
o f these transcripts from scanned autoradiographs. The integrated intensity is
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expressed as the volume o f a band, calculated by sum m ing the volume o f each
pixel w ith in the boundaries o f the band (area x height) and then subtracting the
background fo r each pixel.
W estern b lo t analysis
Western im m unoblots were conducted as previously described (Pari and
St. Jeor, 1990). WT-19 fibroblasts were seeded a t 1 X 106 cells per 100-mm
culture plate w ith media containing 50 U /m l o f recom binant mouse interferon-y
(Gibco/BRL). The follow ing day, cells were mock-infected w ith NIH3T3
supernatant o r infected w ith virus (WT or m utant) a t an m oi o f 2 PFU per cell.
Cell lysates were prepared a t 24 hours after infection, and were precleared w ith
purified mouse IgG (Cappel Organon Teknika Corp., D urham , N.C.) and protein
A-sepharose beads (Sigma Chemical Co.) overnight at 4°C w ith rotation.
Following centrifugation, equal volumes o f precleared lysates were boiled for 5
m inutes, subjected to SDS-PAGE on 12.5% gels, and transferred to
nitrocellulose membranes (Boehringer Mannheim). The blots were treated w ith
protein-blocking solution overnight a t 4°C, and then incubated w ith a p rim aiy
antibody fo r one hour a t room tem perature. A conform ational-independent
antibody to m urine H-2Kb (anti-peptide 8) or ra b bit IgG (control) served as
p rim a iy antibodies. The blots were washed three times, and incubated w ith a
horseradish peroxidase (HRP)-conjugated mouse a n ti-ra b b it secondaiy antibody
(Fischer Biologicals) fo r one hour a t room temperature. Following three more
washes, antibody binding was detected by chemiluminescence (Amersham Life
Science ECL Kit) on F u ji XAR5 film .
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In vivo growth o f MCMV m utants

Three-week-old BALB/c.ByJ weanling mice (Jackson Laboratories, Bar
Harbor, MN) were inoculated w ith 1.5 X 105 PFU o f tissue-culture-passaged
virus (WT o r m utant) by intraperitoneal injection. A t the indicated tim e post
inoculation, mice were sacrificed by cervical dislocation, and th e ir subm axillary
salivaiy glands, spleens, livers, and lungs were removed. The organs were
weighed, and a 20% (weight/volume) tissue homogenate was prepared in
Iscove’s complete media (Iscove’s base [Mediatech], 10% heat-inactivated fetal
bovine serum, 1% L-glutam ine, and 50 p g /m l gentamicin sulfate) using ground
glass tissue homogenizers. Homogenates were transferred to 15 m l conical
tubes, sonicated fo r 30 seconds, and centrifuged fo r 5 m inutes. The resulting
supernatants were titered on NIH3T3 cells by standard plaque assay.
For determ inations o f virus growth in footpads, eight-week-old
BALB/c.ByJ male mice were anesthetized w ith an intraperitoneal injection o f
1.3 mg o f sodium pentabarbital (equivalent to 0.01 m g /kg o f body weight) prior
to footpad inoculations. The mice were then injected subcutaneously (using a
30-gauge needle) w ith 1.5 X 105 PFU o f WT or m utant virus (in 0.1 m l o f
phosphate-buffered saline) in each hind footpad. A t 4 days post-inoculation,
the mice were sacrificed and th e ir hind footpad tissue was removed w ith a
scalpel. The hind footpads from 2 anim als were pooled, weighed, and a 10%
(weight/volume) homogenate was prepared in Iscove’s complete media using
ground glass tissue homogenizers. The homogenate was then transferred to a
15 m l conical tube, sonicated fo r 30 seconds, centrifuged for 5 m inutes, and the
resulting supernatant was titered on NIH3T3 cells by standard plaque assay.

49

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

IV. RESULTS
Preparations necessary fo r constructing recombinant MCMV
Recombinant viruses (RV) expessing the E. coli 3-glucuronidase (3-glu)
m arker gene were constructed by site-directed insertion and deletion
mutagenesis o f the MCMV genome. O ur basic strategy involved inserting the 3glu gene into selected MCMV genomic plasm id clones. The resulting plasmids,
containing the 3-glu m arker gene and interupted or missing genomic
sequences, were linearized and cotransfected w ith infectious MCMV DNA into
m urine NIH3T3 fibroblasts. Following homologous recombination between the
linearized plasm id DNA and the MCMV DNA, plaques containing m utant
viruses were selected by a blue phenotype after overlaying the transfected cells
w ith agarose containing the chromogenic substrate for the 3-glu enzyme (called
X-glu).
Prerequisite experiments were conducted to obtain necessary inform ation
and to establish the optim al conditions needed to generate MCMV m utants by
th is method. These in itia l experiments included the following: (1) mapping
re strictio n endonuclease sites w ith in selected MCMV genomic clones,
(2) coupling the 3-glu gene to a suitable prom oter th a t functions during MCMV
infection, (3) constructing recom bination plasm ids o f mutated MCMV genomic
clones containing the 3-glu m arker gene, (4) isolating inta ct MCMV DNA from
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purified virions, and (5) developing a transfection protocol for linearized plasm id
DNA and MCMV DNA th a t results in productive infection.
Mapping restriction endonuclease sites w ith in MCMV H ind III-J and -I
Two genomic clones, fragments J and I, were selected from a Hind III
lib ra ry o f the S m ith strain MCMV genome to m utate and analyze in th is study.
M utations were targeted to th is region o f the MCMV genome fo r two reasons.
F irst, the H ind III-J and -I fragm ents of MCMV correspond, in map units, to a
cluster o f dispensable HCMV genes, specifically the IRS1 and US1 through
US 13 genes (see Fig. 2). The MCMV and HCMV genomes share conserved
blocks o f homologous gene fam ilies, which show sim ilar map positions and
organizations (Messerle et al., 1992; M ocarski et al., 1990; Rawlinson et al.,
1993). Therefore, it was likely th a t regions in the Hind III-J and -I fragments o f
MCMV would be nonessential. Secondly, two loci w ith in the nonessential
HCMV region shown in Figure 2, namely a gene w ithin US2-5 and the US 11
gene, are involved in down-regulating MHC class I expression in infected hum an
cells (Jones et al., 1995). Therefore, it seemed reasonable to assume th a t the
corresponding region o f the MCMV genome, included w ith in H ind III-J and -I,
may also encode a related nonessential MCMV gene w ith a sim ilar function. To
facilitate in the construction and characterization o f MCMV m utants in this
region o f the vira l genome, the sites for various restriction endonucleases were
determined w ith in the MCMV H ind III-J and -I fragments (shown in Fig. 3).
Coupling the B-glu gene to the e l promoter
Jones and coworkers demonstrated th a t the p-glu gene is an efficient and
stable m arker fo r detecting recom binant HCMV (Jones et al., 1991 and 1992).
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To generate recom binant MCMV using this detection system, the 3-glu gene
m ust firs t be placed under the control o f a prom oter th a t w ill function during
MCMV infection. We chose the MCMV early region 1 (el) prom oter to drive the
expression o f the P-glu gene. This prom oter is efficiently activated by the IE1
and IE3 proteins o f MCMV, and is located w ith in the Hind III-F fragm ent o f the
vira l genome (Buhler et al., 1990). Therefore, plasm id p e l/p -g lu (shown in Fig.
4A) was constructed to contain a cassette o f the P-glu reporter gene coupled to
the e l prom oter (representing the firs t 200 nucleotides upstream o f the sta rt
site o f transcription).
This e l/p -g lu cassette was found to efficiently express the P-glu enzyme
in response to MCMV infection in transient transfection experiments. Plasmid
p e l/P -g lu was transfected into NIH3T3 cells (20 pg o f D N A /1 X 106 cells) by
calcium phosphate precipitation. The following day, the transfected cells were
infected w ith MCMV (moi o f 2), the virus inoculum was removed, and the cells
were overlayed w ith agarose containing X-glu (75 pg/m l). W ithin 48 hours after
infection, approxim ately 40 to 50 blue foci were visible on each plate o f 1 X 106
cells.
C onstruction o f recom bination plasm ids o f m utated MCMV genomic clones
containing the B-glu m arker gene
In th is study, the generation o f recom binant MCMV involved inserting
the e l/p -g lu cassette into the Hind III-J and -I regions o f the vira l genome by
homologous recom bination. In order fo r efficient homologous recom bination to
occur, plasm ids o f the m utated genomic clones m ust be designed so th a t the
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e l/P -g lu cassette is flanked on either side by approxim ately 1.5 kb o f MCMV
genomic sequences (Jones, personal com m unication).
A recom bination plasmid o f an insertion m u ta n t of the MCMV Hind III-J
genomic clone, designated p jp g lu -5 (shown in Fig. 4C), was constructed by
inserting the e l/p -g lu cassette (removed from plasm id p e l/p -g lu by digestion
w ith Sst I) into the second Sst I site w ith in H ind III-J . Recombination plasm ids
representing deletion m utants o f the H ind III-J and -I genomic clones,
designated p jp g lu -6 , pJIpglu-7, and pJipglu-9 (shown in Fig. 4C), were
constructed by deleting selected genomic sequences from Hind III-J and -I and
replacing them w ith the e l/p -g lu cassette. To fa cilita te in the construction o f
these deletion recom bination plasm ids, an additional plasmid was made th a t
contained only the firs t 3.4 kb o f H ind III-J cloned in fro n t o f the e l/p -g lu
cassette. P artial digestion of th is plasm id, called p3.4Jpglu (shown in Fig. 4B),
w ith Sst I produced a linearized molecule opened a t the 3’ end o f the P-glu gene.
Then, various Sst I fragments derived from Hind III-J or -I were cloned behind
the P-glu gene, in the correct orientation, to create deletions in MCMV genomic
sequences. To construct p jp g lu-6 , the 1.9 kb Sst I fragm ent o f H ind III-J was
cloned behind the cassette, thereby deleting 2.8 kb o f Hind III-J genomic
sequences. To create pJiPglu-7, the m iddle 3.0 kb Sst I fragm ent o f Hind III-I
was cloned behind the cassette, resulting in the deletion of 7.7 kb o f genomic
sequences from the H ind III-J and -I regions. To construct pJipglu-9, the 3.7
kb Sst I fragm ent o f Hind III-I was cloned behind the cassette, deleting 10.7 kb
from H ind III-J and -I. Cotransfections o f these recom bination plasm ids w ith
in ta c t MCMV DNA was predicted to in te ru p t or delete sequences o f MCMV Hind
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III-J and -I, provided th a t the recom bination events between the plasm id and
vira l DNAs were homologous.
Isolation o f infectious MCMV DNA and development o f a transfection protocol
fo r recom binant MCMV
The MCMV genome represents a linear, double-stranded DNA molecule
th a t is approxim ately 230 kb in length (Rawlinson et al., 1993). This v ira l DNA
molecule, by itse lf, is infectious when introduced in to permissive cells by
transfection. O ur methods fo r generating m u ta n t MCMV rely on cotransfecting
infectious MCMV DNA and linearized recom bination plasm ids into NIH3T3
fibroblasts, where the DNAs can then undergo homologous recom bination to
create a m u ta n t v ira l genome. Therefore, it was necessaiy to isolate in ta ct
MCMV DNA from virions, and to develop a protocol fo r transfecting th is vira l
DNA into cells th a t resulted in productive infection.
MCMV virions were purified from a virus stock by sorbitol cushion
density gradient centrifugation. The pelleted virions were then lysed, and the
viral DNA was carefully isolated as described in the M aterials and Methods
section. This purified MCMV DNA was transfected into NIH3T3 fibroblasts
using a modified calcium phosphate precipitation technique (Current Protocols
in M olecular Biology, 1987). Determ inations fo r the optim al am ount o f DNA to
transfect and the cell num ber were experim entally derived by titra tio n . The best
results were achieved when a total o f 7 jig o f DNA (including MCMV DNA and
ca lf thym us DNA, as a carrier) was transfected into 3 X 106 cells in suspension.
To increase the cellular uptake o f DNA, cells were shocked w ith 20% dim ethyl
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sulfoxide a t five hours post-transfection. Figure 5 shows the num ber o f viral
plaques resulting from various am ounts o f transfected MCMV DNA.
This basic transfection protocol fo r productive infection was then applied
to transfection for recom binant MCMV. For these experiments, 3 pig o f MCMV
DNA (enough to produce approxim ately 140 plaques per 100-mm tissue culture
plate) was cotransfected w ith 4 jig o f H ind Ill-linearized plasm id DNA (one o f
those shown in Fig. 4C). When the firs t signs o f cytopathic effect were visible,
a t approxim ately 6 to 8 days post-transfection, the cells were overlayed w ith
0.5% agarose. A few days later, when the plaques were large and welldeveloped, a second agarose overlay containing X-glu was applied to the cells.
The X-glu substrate diffused through the firs t agarose overlay to reach any
plaques containing recom binant virus expressing the P-glu enzyme. These
recom binant virus-containing plaques became blue in color w ithin 24 hours of
the second overlay. Typically, there were 4 to 6 blue plaques visible per 100mm plate, indicating th a t about 3% to 4% o f the total plaques on the plate
contained recom binant virus.
Generation o f recom binant MCMV
Using the methods described above, fo u r MCMV m utants were
generated: RV5, RV6, RV7, and RV9 (shown in Fig. 6). RV5 was generated
using the recom bination plasm id pJpglu-5 in cotransfections w ith MCMV DNA,
and is an insertion m utant in w hich the e l/P -g lu cassette was inserted a t the
second Sst I site w ith in H ind III-J. RV6 was constructed using the
recom bination plasm id pJ3glu-6 in cotransfections, and represents a deletion
m utant in w hich 2.8 kb o f vira l sequences w ith in Hind III-J were deleted and
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replaced w ith the el/(3-glu cassette. RV7 was generated w ith the recom bination
plasm id pJipglu-7, and is a deletion m u ta n t m issing 7.7 kb o f MCMV
sequences, 4.7 kb from H ind III-J and 3.0 kb from H ind III-I. And RV9 is a
deletion m utant, constructed using the recom bination plasm id pJipglu-9, that
lacks 10.7 kb o f MCMV sequences, 4.7 kb from H ind III-J and 6.0 kb from Hind
III-I.
Each RV was subjected to a t least five rounds o f plaque purification,
before a high-titered virus stock was prepared. Southern b lo t analyses were
then conducted w ith DNA isolated from RV-infected NIH3T3 cells, to verify each
targeted m utation to the MCMV genome, and to determine if any contam inating
WT virus was present in the RV stocks. Figure 7 illustrates the results o f these
Southern blot analyses using probes to H ind III-J , H ind III-I, and the p-glu
gene. Table 2 lists the sizes o f the expected hybridizing DNA fragm ents
resulting from digestion w ith the indicated restriction endonucleases (RE) and
hybridization w ith the indicated probe (Fig. 4C includes RE sites used fo r these
size determinations). For a ll fo u r m utants, the sizes o f the recom binant bands
were exactly w hat was predicted from the RE map o f the H ind III-J and -I
regions (see Figs. 3 and 4C), verifying th a t the recom bination events between
the plasm id and MCMV DNAs were homologous. In addition, over-exposures o f
the Southern blots o f RV5, RV6, and RV7 failed to reveal the presence o f WT
bands, indicating th a t the stocks o f these m utant viruses were pure and free o f
any WT MCMV. In contrast, Southern b lo t analysis o f RV9 clearly revealed the
presence o f WT bands in addition to the recom binant bands. It was evident
from these blots th a t approxim ately one-half o f the vira l DNA isolated from cells
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infected w ith RV9 is WT MCMV DNA. Three independent attem pts were made
to fu rth e r p u rify the RV9 stock, b u t were unsuccessful. This finding suggested
th a t RV9 is a helper-dependent m utant, in th a t its replication required the
presence o f WT MCMV. The deletions constructed in th is virus m ust, therefore,
extend into an essential region o f the viral genome, and WT virus acts as a
“helper” to provide an essential gene product in trans. Because the isolation o f
a pure RV9 stock was not possible, th is m u ta n t was not included in subsequent
experiments described below.
In vitro growth o f MCMV m utants in cells o f fibroblast and myeloid origin

To assess whether MCMV H ind III-J or -I sequences have a role in the
growth o f virus in cell culture, the growth rate o f WT and m utant viruses were
determined in m urine fibroblast and macrophage cell lines. In vitro, CMV is
routinely propagated in fibroblasts, and has been extensively adapted to growth
in th is cell type. V irus growth was examined in im m ortalized fibroblasts
(NIH3T3 cells), as well as in p rim a iy fibroblasts isolated from BALB/c mouse
embryos. V irus growth in tissue-culture-adapted macrophages was also
examined, because th is cell type plays an im portant role during pathogenesis,
particularly in dissem ination and latency. Although, in vivo, the virus
characteristically replicates in epithelial cells, there are no available epithelial
cell lines in w hich to test the in vitro growth rate o f these m utants.
Figure 8 represents m u lti-step growth curves of the MCMV m utants in
NIH3T3 fibroblasts (shown in Fig. 8A), and in prim aiy em biyo fibroblasts
(shown in Fig. 8B). In th is experiment, subconfluent cultures o f cells were
infected w ith virus a t a m u ltip lic ity o f 0.1 plaque-form ing u n its (PFU) per cell, or
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one in eveiy ten cells was infected. Then, a t the indicated times follow ing
infection, to ta l virus (intracellular and extracellular) was harvested and
quantitated. In th is type o f growth curve, the am ount o f virus a t each time
po in t depends on both the rate o f virus replication, as well as virus spread from
cell to cell. The growth rate o f each RV in NIH3T3 fibroblasts (see Fig. 8A) was
sim ilar to th a t o f WT MCMV, confirm ing th a t the m utations introduced into
these viruses are nonessential fo r MCMV replication in cultured fibroblasts.
Although the growth o f RV7 in itia lly was lower than th a t o f the other viruses,
th is difference was less than one log and was evident fo r only the firs t three
days post-infection. By the fo u rth day after infection, the levels o f RV7 were
alm ost identical to those o f WT MCMV. In p rim a iy embiyo fibroblasts (see Fig.
8B), RV7 grew as efficiently at WT virus, indicating th a t this large deletion to
the MCMV genome did not affect virus growth in p rim aiy fibroblasts.
Figure 9A shows m ulti-step growth curves o f the m utant viruses in IC-21
macrophages, an SV40-transformed peritoneal macrophage cell line, which is
fu lly permissive for WT MCMV infection. In th is fully-differentiated macrophage
cell line, RV5 and RV6 grew sim ilarly to WT virus, however, the growth o f RV7
in these cells was significantly reduced, by as m uch as 1,000-fold.
The reduced growth rate o f RV7 in IC -21 macrophages could be the
result o f a defect in virus replication, a defect in cell-to-cell spread, or defects in
both replication and spread. To distinguish among these possibilities, a onestep growth curve o f RV7 was conducted in these macrophages (shown in Fig.
9B). In th is experiment, the cultures were infected w ith 5 PFU per cell to
ensure th a t a ll o f the cells were infected sim ultaneously. Therefore, any
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differences observed between viruses reflects differences in virus replication,
since any effects o f cell-to-cell spread are eliminated. Again, the growth o f RV7
was significantly lower than th a t o f WT MCMV, by 100-fold from day 2 post
infection. The reduction in RV7 growth in th is experiment was approxim ately
one log less than th a t observed in the previous experiment. These data indicate
th a t the reduced growth o f th is m utant in IC-21 macrophages is p rim a rily due
to a defect in virus replication, although a defect in cell-to-cell spread may play
some, albeit a m inor, role. In addition, th is experiment clearly demonstrates
th a t the reduced growth o f RV7 in these macrophages is not merely the result of
a slower replication rate, since WT and RV7 viruses reached their peak levels by
2 days post-infection and then remained a t these levels for the duration o f the
experiment.
In a ll o f the in vitro growth curves described above, virus tite rs were
quantitated by standard plaque assay on NIH3T3 fibroblasts. In these plaque
assays, it was consistently observed th a t RV7 produced plaques th a t were
sm aller in size than those produced by WT MCMV or the other m utants. This
observation suggests th a t RV7 may have reduced capabilities in cell-to-cell
spread in NIH3T3 fibroblasts. However, th is defect is probably m inor, as is also
the case in IC -21 macrophages, and does not im pact significantly on the growth
o f RV7 in these fibroblasts.
In vitro analysis o f IE. E. and L gene expression in RV7-infected cells

To further investigate the defect in RV7 replication in IC-21
macrophages, Northern blo t analyses were conducted to determine a t which
stage o f the replication cycle the block in growth occured. Total RNA was
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isolated from infected NIH3T3 and IC-21 cells under immediate early, early, or
late conditions; and was hybridized to probes o f known IE, E, or L genes,
respectively (shown in Fig. 10). Figure 10A is a Northern blo t o f immediate
early RNAs, isolated a t three hours post-infection, hybridized to a probe o f the
IE1 and IE2 genes (both contained w ith in the Hind III-L fragment). IE1 gene
expression (represented by the 2.75 kb transcript) in RV7-infected IC-21
macrophages was greatly reduced, when compared to levels observed in WT- or
RV6-infected cells. Densitom etric scanning o f the autoradiograph revealed over
an 8-fold reduction in the levels o f the 2.75 kb IE1 tra n scrip t in RV7-infected
cells as compared to WT MCMV-infected cells (integrated intensities o f 10.25 for
RV7 and 82.67 for WT MCMV). In contrast, there were no significant
differences in IE 1 gene expression among WT and m utant viruses in infected
NIH3T3 cells (integrated intensities o f 37.24, 32.56, and 37.96 for WT-, RV6-,
and RV7-infected cells, respectively). This reduction in RV7 IE gene expression
in IC-21 macrophages correlates w ith the reduced growth o f th is m utant virus
in these cells, and strongly suggests th a t the block in RV7 replication occured
a t or before the immediate early phase o f virus replication.
Because subsequent virus gene expression in permissive cells is
dependent on IE gene products, one consequence of reduced IE gene expression
would be reduced E and L gene expression as well. Therefore, E and L gene
expression were also investigated by Northern blot analyses in RV7-infected IC21 macrophages. Total RNA was isolated from infected NIH3T3 and IC -21 cells
under early conditions (at 24 hours post-infection in the presence o f
phosphonoacetic acid, an in h ib ito r o f the vira l DNA polymerase) and was
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hybridized to a probe o f the e l gene (shown in Fig. 10B), w hich produces two
transcripts o f 2.6 and 3.0 kb. The 2.6 kb tra n scrip t represents the fu lly
processed e 1 mRNA, and during a norm al infection o f p rim a iy em biyo
fibroblasts (in the absence o f phosphonoacetic acid), the larger 3.0 kb RNA
species is seen m ainly a t 2 hours post-infection and quickly disappears after
this time po in t (Buhler et al., 1990). The strong expression o f the 3.0 kb
species in th is experim ent may be related to the presence o f phosphonoacetic
acid to selectively re strict MCMV replication to the immediate early and early
phases o f replication. However, because the 2.6 kb species represents the
m ature mRNA for the e l gene, differences in the expression o f th is transcript
were compared among WT- and m utant-infected cells. Expression o f the 2.6 kb
e l tra n scrip t in RV7-infected IC-21 macrophages was reduced over 6-fold
compared to expression in WT-infected cells (integrated intensities o f 2.39 for
RV7 and 14.62 fo r WT MCMV). Whereas, there were no significant differences
in e l expression between WT and RV7 viruses in infected NIH3T3 fibroblasts
(integrated intensities o f 24.41 fo r WT MCMV and 20.49 for RV7).
To examine L gene expression, to ta l RNA was isolated a t late times (at 24
hours after infection), and was hybridized to a probe o f the glycoprotein B (gB)
gene, a true L gene in MCMV (shown in Fig. 10C). In IC-21 macrophages, there
was over a 20-fold reduction in the levels o f gB transcripts (m igrating at 3.3 kb)
in RV7-infected cells as compared to WT-infected cells (integrated intensities of
0.27 for RV7 and 5.47 fo r WT MCMV). In NIH3T3 fibroblasts, the levels o f gB
transcripts in RV7-infected cells were also reduced, by less than 5-fold, when
compared to W T-infected cells (integrated intensities o f 2.44 fo r RV7 and 11.69
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for WT MCMV). The reason fo r th is reduction in RV7-infected NIH3T3 cells is
unknow n, b u t may be related to the in itia lly delayed kinetics o f RV7 replication
in these cells (see Fig. 8A), or to the sm aller plaque size consistently observed
w ith RV7 infection in these cells. Nevertheless, the drastically reduced L gene
expression evident in RV7-infected IC-21 macrophages correlates w ith the
significantly reduced levels o f IE and E gene expression, and suggests th a t poor
replication o f RV7 in these cells is due to inadequate IE vira l gene expression.
In vitro analysis o f RV7 entry

A possible explanation for the defect in RV7 replication and reduced IE
gene expression in IC-21 macrophages is th a t RV7 is not entering these cells as
efficiently as WT MCMV. Perhaps the defect lies upstream o f IE gene
expression, during the attachm ent and penetration phases o f infection. To
investigate th is possibility, duplicate cultures o f cells were infected
sim ultaneously, and at three hours post-infection, RNA was harvested from one
culture fo r Northern blot analysis (of IE1 gene expression) and DNA was
harvested from the other culture fo r Southern blot analysis (of in p u t vira l DNA)
(shown in Fig. 11). I f RV7 does not enter IC-21 macrophages as efficiently as
WT MCMV enters, then the Southern b lo t should reveal a band o f lesser
inte nsity in the DNA isolated from RV7-infected cells as compared to WTinfected cells. On the contrary, the Southern blot (see Fig. 11A) clearly
dem onstrates th a t RV7 entered these macrophages as efficiently as WT MCMV.
Densitom etric scanning o f the autoradiograph revealed veiy sim ilar intensities
o f the v ira l DNA present in RV7- and WT-infected cells a t three hours post
infection (integrated intensities o f 10.12 fo r RV7 and 10.80 fo r WT MCMV). In

62

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

NIH3T3 cells, the entry o f RV7 appeared to be slightly less than th a t o f WT
MCMV (integrated intensities o f 13.06 fo r RV7 and 21.07 for WT MCMV),
although th is difference is less th a t 2-fold and is probably not significant.
Results o f the sim ultaneous N orthern blo t (see Fig. 1IB) were s im ilar to
those shown in Figure 10A. There was alm ost a 9-fold reduction in the levels o f
the IE1 tra n scrip t present in RV7-infected IC-21 macrophages when compared
to WT-infected cells (integrated intensities o f 1.99 fo r RV7 and 17.11 fo r WT
MCMV). In NIH3T3 fibroblasts, there was a slight reduction in the levels o f IE1
transcripts in RV7-infected cells as compared to WT-infected cells (integrated
intensities o f 5.33 for RV7 and 9.58 fo r WT MCMV). However, this difference is
less than 2-fold, and may reflect the slig h tly reduced entry o f RV7 in to these
cells in this particular experiment (see Fig. 11A). Collectively, these data
demonstrate th a t the reduction in IE gene expression observed in IC-21
macrophages infected w ith RV7 is not the re su lt o f a defect in virus entry.
In vitro analysis o f effects o f MCMV m utants on MHC class I expression

It is well-established th a t both MCMV and HCMV down-regulate the
expression o f MHC class I molecules on the surface o f infected cells (Barnes et
al., 1992; Beersma et al., 1993; Campbell et al., 1992 and 1994; Del Val et al.,
1992; Jones et al., 1995; Yamashita et al., 1993), although the mechanisms o f
th is reduction by these viruses are different. Two HCMV loci involved in class I
down-regulation, specifically the US2-5 and US 11 loci, have been identified
w ith in the cluster o f nonessential HCMV genes shown in Figure 2 to align, in
map units, w ith the Hind III-J and -I fragm ents o f the MCMV genome (Jones et
al., 1995). Because the genomes o f HCMV and MCMV show a colinear
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arrangement o f many genes (Messerle et al., 1992; M ocarski et al., 1990;
Rawlinson et al., 1993), the nonessential regions identified in H ind III-J and -I
o f the MCMV genome may encode a related gene involved in class I downregulation in infected m urine cells. Therefore, the MCMV m utants were
analyzed by Western blot w ith an antibody to the H-2Kb class I heavy chain to
determine if sequences w ith in H ind III-J or -I were involved in MHC class I
expression (shown in Fig. 12). WT MCMV, as w ell as RV5, RV6, and RV7,
significantly reduced the level o f the H-2Kb heavy chain in infected fibroblasts.
This indicated th a t the nonessential regions o f H ind III-J and -I m issing in these
m utants were not involved in class I down-regulation. I f these regions o f the
MCMV genome were involved in th is phenomenon, then these m utants would
have failed to down-regulate class I expression, and class I levels sim ilar to
those observed in mock-infected cells would have been expected.
In vivo analysis o f MCMV m utants

To assess the a bility o f recom binant MCMV to replicate in itivo, the
growth o f each m utant virus was determined in the salivaiy glands, spleen,
liver, and lungs o f infected mice. BALB/c weanling mice were inoculated w ith
tissue-culture-passaged virus by the intraperitoneal route, and virus titers in
these organs were determined a t 3, 7, 10, and 14 days after inoculation. In the
salivaiy glands (shown in Fig. 13A), the replication o f RV5 was significantly less
than th a t o f WT MCMV, reaching a peak tite r a t 14 days post-inoculation th a t
was two logs lower than peak WT levels. The replication o f RV6 in the salivaiy
glands was even lower than th a t o f RV5, reaching peak levels th a t were four
logs less than th a t observed for WT virus. And m ost dram atically, RV7 could
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not be detected by standard plaque assay o f salivary gland homogenates in this
experiment.
To determine if the growth o f these m u ta n t viruses in the salivary gland
was perhaps delayed, tite rs in th is organ were determined a t 2, 4, and 6 weeks
after intraperitoneal inoculation (shown in Fig. 13B). Again, a t 2 weeks post
inoculation, RV5 grew to the highest tite r among the m utants, b u t was less
than th a t o f WT MCMV. However, th is difference was less than one log in this
experiment, maybe because the glands from three anim als were pooled before
homogenization (whereas each gland was homogenized and titered individually
in the previous experiment). A t th is same tim e point, RV6 grew poorly (three
logs lower than th a t o f WT MCMV) and RV7 was barely detectable. By 6 weeks
post-inoculation, the titers for a ll the viruses were no longer detectable by
plaque assay, indicating th a t these m utants do not display a delayed kinetics
fo r salivary gland growth. Instead, it is evident th a t the genes deleted in these
viruses are required for the efficient replication o f MCMV in the salivary gland.
It is interesting to note th a t the more extensive the m utation in the vira l
genome, the poorer the a bility o f the m u ta n t virus to replicate in the salivary
gland. This suggests th a t m ultiple genes may be involved in salivary gland
growth, and th a t the effects o f deleting increasing numbers o f these genes may
be additive on reducing salivary gland growth.
In the spleens o f infected mice, WT MCMV could be detected on days 7
(at an average o f 104 PFU /m l o f homogenate) and 10 (average o f 10 PFU/m l).
However, none o f the m utant viruses could be detected in the spleen a t any o f
the four tim e points examined. In the lungs, WT virus was detected only on day

65

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

10 post-inoculation, a t a tite r o f 1,020 P F U /m l o f homogenate. Again, none o f
the m utant viruses were detected by plaque assay o f lung homogenates. In the
liver o f infected anim als, neither WT nor m u ta n t MCMV was detected in this
experiment. Although the MCMV m utants d id not replicate to detectable levels
in the spleen, lungs, or liver o f infected mice, the levels o f WT viru s detected in
these organs were too low to make any valid comparisons between WT and
m utant MCMV growth. In th is study, the anim als were inoculated w ith tissueculture-passaged virus, w hich is greatly attenuated in vivo, and does not grow
well in m ost organs, w ith the exception o f the salivary gland (Jordan and
Takagi, 1983; Osborn and W alker, 1970). Because the m utants grew so poorly
in the salivary gland, it was not possible to obtain the more virule n t salivaiygland-passaged viruses required fo r th is type o f experiment. As a result,
conclusions concerning the growth o f these MCMV m utants in the spleen, liver,
and lungs o f infected mice cannot be made.
The growth o f each m utant virus was also quantitated in the footpads o f
mice inoculated subcutaneously in th e ir h in d footpads. This experim ent was
conducted to determine the feasibility o f exam ining the CTL response to each
m utant in vivo, w hich is quantitated by lim itin g d ilu tio n analysis o f the popliteal
lym ph nodes draining infected footpads (Campbell et al., 1989). The lim itin g
d ilu tio n analysis measures the frequency o f CTL precursors, present in the
lym ph nodes o f inoculated mice, th a t were prim ed and activated in vivo in
response to virus infection. However, p rio r to conducting this cumbersome
analysis, it was im portant to determine w hether the virus m utants were capable
o f replicating in the tissues o f the footpad. Otherwise, a reduced CTL precursor
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frequency could be the re su lt o f poor virus replication in the footpad, thereby
reducing the am ount o f antigen present, and would not accurately represent the
im m unogenicity o f the m utants. Figure 14 illustrates th a t a t 4 days post
inoculation, the growth o f the m utant viruses in the footpad was significantly
lower than th a t o f WT MCMV. Because a ll o f the m utants displayed
significantly reduced growth in footpad tissues, comparisons o f CTL precursors
generated by WT virus and the RV m utants would not be valid.
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V. DISCUSSION
Nonessential MCMV genes are located in the Hind III-J and -I fragments
In th is study, nonessential regions o f the MCMV genome were identified
w ithin the H ind III-J and -I fragments. More specifically, the right-m ost 4.7 kb
o f Hind III-J and the left-m ost 3.0 kb o f H ind III-I (sequences deleted in RV7)
are nonessential fo r virus replication in tissue culture. The DNA sequences of
the Hind III-J (8.1 kb in length) and -I (9.7 kb in length) fragments have been
obtained from the data base o f a current project to determine the complete DNA
sequence o f the MCMV (Smith) genome (Rawlinson et al., 1993). Previous
tra n scrip t m apping experiments revealed th a t there is no immediate early
transcription from the H ind III-J and -I regions o f the MCMV genome (Keil et al.,
1984). However, a t early and late times after infection, transcription from a ll of
the Hind III fragm ents occurs (Keil et al., 1984).
RNA transcripts encoded w ithin the H ind III-J fragm ent were identified
by hybridizing infected cell RNA, isolated a t early or late times, w ith various
probes prepared from th is fragm ent (Vieira et al., 1994). This region o f the
MCMV genome was found to encode seven early transcripts and one late
transcript, a ll o f w hich are transcribed in the leftward direction (Thale et al.,
1994; Vieira et al., 1994). The DNA sequence o f the H ind III-J fragment was
then analyzed fo r the presence o f protein coding sequences containing in itia to r
m ethionine codons whose context resembled the Kozak consensus sequence for
translation in itia tio n (Kozak, 1989). Using th is criterion, seven open reading
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frames (ORF) were identified w ith in Hind III-J , a ll o f them oriented in the same
leftward direction on the MCMV genome (shown in Fig. 15). Because the
sequence analysis o f the entire MCMV genome has not been completed, these
ORFs have been tem porarily designated HJ1 through HJ7 (for Hind III-J 1
through 7).
To date, there have been no published reports o f fine RNA tra n scrip t
mapping experim ents using probes prepared from the H ind III-I region o f the
MCMV genome. Prelim inary data o f some transcripts encoded w ith in Hind III-I
comes from the above described experiments o f tra n scrip t mapping using
probes from H ind III-J . From these studies (Thale et al., 1994; Vieira et al.,
1994), it is known th a t the sta rt sites o f the early 4.1, 6.0, and 7.4 kb
transcripts lie in the adjacent Hind III-I fragment. The DNA sequence o f the
entire Hind III-I fragm ent was analyzed by the method o f Fickett for the
detection o f potential protein coding regions, o r ORFs. The crite ria used to
select these potential ORFs were: (1) the presence o f an in itia to r m ethionine
codon whose context sequence resembled the Kozak consensus sequence
(RNNATGG) fo r translation in itia tio n , (2) those th a t were oriented in the leftward
direction on the v ira l genome, and (3) those th a t did not overlap any other
potential ORF. The results o f th is analysis (shown in Fig. 16) indicate th a t
there are 6 potential ORFs encoded w ith in Hind III-I. Open reading frames were
chosen based on a leftward orientation because it is known th a t the three
largest transcripts mapped to H ind III-J in itia te in the adjacent Hind III-I
fragment and are transcribed in a leftw ard direction (Thale et al., 1994; Vieira et
al., 1994). B u t u n til fu rth e r tra n scrip t mapping experiments are conducted, it
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is not known if any o f these represent bonafide ORFs. Nevertheless, it can be
concluded th a t the RV7 deletion removes the MCMV sequences encoding the
early 1.3, 1.9, 4.1, 6.0, and 7.4 kb transcripts (see Figs. 15 and 16). In
addition, the RV9 deletion may remove sequences encoding two more potential
ORFs, one or both o f w hich may be essential fo r MCMV replication in vitro.
Recently, M ocarski and coworkers have constructed recom binant viruses
cariying insertions w hich d isru p t each o f the ORFs predicted to exist in the
Hind III-J fragm ent (Cardin et al., 1993; V ieira et al., 1994). The growth
kinetics o f a ll m u ta n t viruses are the same as WT virus, dem onstrating th a t a ll
o f the genes encoded in the H ind III-J fragm ent o f the MCMV genome are
dispensable fo r growth in cultured fibroblasts. W ith the exceptions o f the
m utants disrupting the HJ1 and HJ2 ORFs, these MCMV m utants have not
been evaluated in the infected mouse, therefore the functions of these vira l
genes in vivo are not known.
The single late transcript, w hich begins in Hind III-J and crosses the
Hind III-J /L ju n ctio n , contains the HJ1 ORF. MCMV m utants cariying
insertions in th is ORF have been extensively studied in the infected mouse, but
have failed to identify a function fo r th is late gene in vira l replication, tissue
tropism , o r latency (Cardin et al., 1993).
The sg g l gene includes the HJ2 and HJ3 ORFs, and encodes two 3’coterm inal early tra n scrip ts o f 1.5 and 1.8 kb in size (Lagenaur et al., 1994).
The more abundant 1.5 kb tra n scrip t contains the HJ2 ORF and encodes a 37
kilodalton (kd) protein, designated Sggl. The 1.8 kb tra n scrip t initiates
upstream o f the 1.5 kb tra n scrip t and contains the HJ3 ORF, in addition to the
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HJ2 ORF. However, the H J3 ORF is not translated, therefore th is longer
transcript also encodes the 37 kd Sggl protein (Lagenaur et al., 1994).
Recombinant viruses carrying m utations disrupting the expression o f the Sggl
protein grow very poorly in the salivary glands o f inoculated mice, while growth
in the liver and spleen are not significantly affected (Manning et al., 1992).
S g g l -deficient viruses m a in ta in the a bility to disseminate in the infected mouse

and to enter serous a cin a r epithelial cells, although they fa il to replicate
efficiently in this cell type (Lagenaur et al., 1994). These results indicate th a t
the sg g l gene o f MCMV is required for high levels o f vira l replication in the
salivary glands. Incidentally, a ll o f the MCMV m utants constructed in th is
study contain an in ta c t s g g l gene, yet fa il to replicate efficiently in the salivary7
glands o f infected mice. These data indicate th a t there are other MCMV genes,
in addition to the s g g l gene, w hich influence vira l replication in the salivary
glands.
The f c r l gene o f MCMV includes the HJ6 ORF, and produces one early
transcript of 1.9 kb, w hich encodes an Fc receptor for IgG (Thale et al., 1994).
The products o f the f c r l gene are glycoproteins o f 86-88 and 105 kd, and
represent homologs o f the gE proteins o f three alpha-herpesviruses, HSV-1,
varicella zoster virus (VZV), and pseudorabies virus (PRV) (Thale et al., 1994;
Whealy et al., 1993). In HSV-1, VZV, and PRV, the Fc receptors consist o f a
heterodimer o f the gE and gl proteins, both o f w hich are needed to bind IgG
(Johnson et al., 1988; L itw in et al., 1990). W hether the MCMV Fc receptor is
composed of a sim ilar heterodim er is unknown a t the present tim e. Although
HCMV also expresses an Fc receptor for IgG, there is no homologue of the f c r l
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gene found in the HCMV genome (Thale et al., 1994). A t present, MCMV
m utants deleted o f the f c r l gene have n o t been evaluated in a mouse model,
therefore, the functional relevance o f th is gene product during MCMV infection
is unknown. In a ra t model o f PRV infection, the gE-gl heterodimer is required
fo r the transneuronal transport o f virus from the retina to several regions o f the
brain (Whealy et al., 1993). Thus, eventhough gE and gl are both nonessential,
they function in concert to affect neurotropism o f PRV in the ra t brain.
Presently, a gl homologue has not been identified in MCMV. Nonetheless, it is
possible th a t MCMV gE, acting alone or in conjunction w ith other vira l proteins,
may influence tropism to macrophages.

Another hypothesis, w hich is

supported by in vitro data, is th a t this Fc receptor functions to modulate the
activity o f virus-specific antibodies. For example, the HSV-1 Fc receptor is
capable o f antibody bipolar bridging o f a n tivira l IgG molecules (Frank and
Friedman, 1989). This refers to the binding o f a single IgG molecule (directed
against HSV-1 gC or gD) by its Fab end to gC or gD, while the Fc end o f the
same molecule binds to the HSV-1 Fc receptor. By engaging the Fc end o f
a n tivira l IgG, HSV-1 resists antibody- and complement-dependent
neutralization. Alternatively, the Fc binding activity o f the f c r l gene product
may be irrelevant to its in vivo function, and may instead indicate a propensity
o f this molecule to interact w ith other proteins. In fact, in vivo studies
conducted in im m unoglobulin-deficient mice indicate th a t the absence o f
antibodies does not alter the course and the kinetics of prim ary MCMV infection
(Jonjic et al., 1994). In th is study, the RV6 deletion includes the entire HJ6
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ORF, however, the phenotype o f this m utant cannot be solely attributed to the
lack o f the f c r l gene, because the deletion also includes m ost o f the HJ5 ORF.
The rem aining transcripts encoded in the H ind III-J fragm ent o f the
MCMV genome are uncharacterized in term s o f the protein products they
encode and th e ir functions during infection. Three o f the larger early
transcripts (the 4.1, 6.0, and 7.4 kb transcripts) are predicted to in itia te in the
adjacent Hind III-I fragm ent. The deduced amino acid sequences encoded by
the seven ORFs in H ind III-J were screened by com puter analysis to determine
if they possessed homology to any HCMV ORFs, and only one product was
found to exhibit significant sim ilarity. The product o f the HJ7 ORF possesses
homology w ith the US22 gene fam ily of HCMV (Vieira et al., 1994). The US22
gene fam ily o f HCMV consists o f 13 ORFs, one o f w hich encodes the
nonessential IRS1 gene (Chee et al., 1990) (see Fig. 2). This protein has
transcriptional transactivating activities, and is believed to cooperate w ith the
IE1 and IE2 proteins o f HCMV to activate other vira l prom oters (Stasiak, 1991).
I f the protein encoded by the MCMV HJ7 ORF, w hich is deleted in RV7, has
sim ilar transcriptional transactivating capabilities, then perhaps the defects
displayed by th is m utant virus (poor growth in macrophages, and ina b ility to
grow in salivary glands) may be due, in part, to the absence o f such a
transactivator. There are no homologues to HCMV in either the nucleic acid
sequences of H ind III-I (Rawlinson et al., 1993) or in the deduced amino acid
sequences encoded by the six potential ORFs in Hind III-I.
Collectively, the MCMV m utants created by M ocarski and his colleagues
demonstrate th a t a ll o f the vira l genes encoded w ithin H ind III-J are
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nonessential. However, a function fo r only one o f these gene products, the Sggl
protein, has been identified in vivo (Lagenaur et al., 1994; M anning et al., 1992).
In addition, a ll o f the m utants created by th is group consist o f insertions or
sm all deletions w hich d isru p t the expression o f only one v ira l gene product in
each m utant. In contrast, the virus m utants generated in th is study cany' large
deletions, spanning up to 10.7 kb o f MCMV sequences, and are predicted to
d isru p t the expression o f m ultiple MCMV genes sim ultaneously. This may
become im portant in identifying phenotypes fo r these m utants. Because the
MCMV genome is estim ated to contain 200 genes (Rawlinson et al., 1993), any
one o f these vira l genes, by itself, may be expected to play a subtle role during
vira l pathogenesis. Or, perhaps two or more vira l genes act together to
influence a p a rticu la r aspect o f pathogenesis. Therefore, identifying a function
for any one o f these genes, by itself, may be d ifficu lt. And indeed, th is appears
to be the case w ith some o f M ocarski’s MCMV m utants. Extensive in vivo
evaluations o f those m utants disrupted in the IE2 gene or in the late gene
encoded at the H ind III-L /J ju n ctio n have failed to identify functions for these
genes in the infected mouse (Cardin et al., 1993). Although it is possible that
MCMV evolved to carry’ genes th a t are unnecessary, it is more likely th a t the
correct experim ental conditions required to observe the true functions o f these
genes have not been found.
From Figure 15, it is predicted th a t the m utation in RV5 may disrupt the
expression o f fo u r RNA transcripts: the in itia tio n o f the early 1.9 kb transcript
encoding the Fc receptor, and the polyadenylation o f the 4.1, 6.0, and 7.4 kb
transcripts. The deletion constructed in RV6 deletes two ORFs, HJ5 and HJ6,
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and deletes the polyadenylation signal fo r the three largest transcripts mapped
to the H ind III-J region. The deletion in RV7 deletes three ORFs in H ind III-J ,
namely HJ5, HJ6, and HJ7, and also deletes the region in Hind III-I from w hich
the three larger transcripts are produced (see Fig. 16). W ith the exception o f the
Fc receptor, nothing is known o f the gene products encoded by these
transcripts. A t present, it is unclear w hether the RV5 insertion significantly
affects the synthesis, structure, or fu n ctio n o f any o f these vira l gene products.
However, m utant viruses RV6 and RV7 lack the vira l sequences encoding
m ultiple RNA transcripts, and are therefore defective in the production o f
several MCMV gene products.
The helper-dependence o f RV9 indicates th a t the deletion constructed in
th is m u ta n t extends into an essential region o f the MCMV genome. Therefore,
an essential gene or genes required fo r MCMV replication in cultured fibroblasts
resides w ith in the 3.0 kb o f Hind III-I sequences deleted in RV9 b u t present in
RV7. Alternatively, it is possible th a t th is region carries one copy o f an
essential gene product present in duplicate copies in the Hind III-J and -I
fragm ents o f the MCMV genome. In th is case, the deletion o f one copy o f the
gene is not detrim ental, b u t the deletion o f both copies (possibly occuring in
RV9) is lethal. Because many herpesviruses, including HCMV and HSV, consist
o f two sets o f unique sequences (Us and U l) each flanked by repeated sequences
(see Fig. 1), genes mapping to these repeated sequences are present in two
copies per vira l genome. Although the MCMV genome contains no repeated
DNA sequences, redundant MCMV genes may s till exist, i f not in sequence,
then possibly in function.
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Nonessential MCMV genes within Hind III-J and -I are not involved in MHC
class I expression
The MCMV sequences identified as nonessential w ith in H ind III-J and -I
are not involved in the down-regulation o f MHC class I expression observed in
infected cells. In itia lly , th is finding was surprising, since the corresponding
region o f the HCMV genome, specifically the US2-5 and US11 loci, are involved
in class I reduction in infected hum an cells (Jones et al., 1995). However, upon
more careful consideration, th is result was not so unexpected.
Eventhough the MCMV and HCMV genomes show significant sequence
homology and a colinear arrangem ent o f many genes, these sim ilarities apply
prim arily to essential genes (Messerle et al., 1992; M ocarski et al., 1990;
Rawlinson et al., 1993). In general, essential genes w ith critic a l functions,
including the m ajor IE proteins (IE1 and IE3 o f MCMV, and IE1 and IE2 of
HCMV), the DNA polymerase, the MDBP, the ICP18.5 homolog, and the gB
protein, display high degrees o f amino acid sequence homology between the
viruses. In addition, these essential genes are organized in exactly the same
order along the vira l genomes, and show sim ilar map positions. However,
outside o f these conserved blocks o f homologous essential genes, the MCMV
and HCMV genomes show very little homology. In fact, the H ind III-J and -I
fragments o f the MCMV genome show only m arginal sim ilarity to any portion o f
the HCMV genome (Rawlinson et al., 1993; Vieira et al., 1994).
Because th is region o f the MCMV genome, and the corresponding region
o f the HCMV genome, are nonessential, they are predicted to im pact on the
interaction of the virus w ith its host. These nonessential regions o f the MCMV

76

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

and HCMV genomes are divergent, probably because they coevolved separately
w ith in th e ir respective hosts fo r a period o f 30 m illion years (H ill and Ploegh,
1995). D uring this evolutionary process, MCMV evolved the means to in h ib it
the antigen presentation system present in the mouse, and HCMV evolved
mechanisms to interact w ith the antigen presentation system present in the
hum an. Indeed, both viruses prevent class I molecules from leaving the
endoplasmic reticulum (ER), however, the mechanisms utilized by the viruses
are quite different. In MCMV-infected cells, class I molecules are loaded w ith
peptide, b u t rem ain trapped in the ER, where they accumulate (Del Val et al.,
1992). In addition, there is a defect in the synthesis o f class I molecules in
MCMV-infected cells (Campbell et al., 1992 and 1994). In HCMV-infected cells,
conform ationally in ta ct MHC class I molecules are assembled, however, they
are unstable and are rapidly degraded shortly after th e ir synthesis (Beersma et
al., 1993; W arren et al., 1994). In addition, the HCMV-induced in sta b ility in
class I assembly is specific fo r hum an class I molecules. In m urine fibroblasts
transfected w ith a hum an class I molecule, hum an leukocyte antigen B27 (HLAB27), HCMV infection specifically decreased the expression of HLA-B27, but
had no effect on the expression o f the endogenous m urine H-2Kk molecules
(Beersma et al., 1993). In a recent review article (1995), H ill and Ploegh wrote
th e ir opinions concerning th is divergent evolution o f MHC class I in h ib itio n by
different viruses:
“We see th is interaction between the evolution o f antigen presentation
and viral-evasion mechanisms as rather like a prolonged chess game between
well-m atched players. From the same starting point, different paths are
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followed, depending on the moves o f the opponent. It is clear th a t the evolution
o f class I-restricted antigen presentation has affected the evolution o f the
viruses..., and we contend that the p a rticu la r viral-evasion strategies developed
have, in tu rn , influenced the evolution o f antigen presentation w ith in each
species.”
As a note, prelim inaiy data indicate th a t an MCMV gene influencing
MHC class I transport lies in the H ind III-E fragm ent o f the viral genome
(Koszinowski, personal com m unication), and another vira l gene involved in the
in h ib itio n o f antigen presentation to CTLs is located in the Hind III-A fragm ent
(H ill, personal communication).
Nonessential regions of H ind III-J and -I are required for efficient MCMV
replication in the salivary glands
Nonessential regions o f MCMV H ind III-J and -I identified in th is study
are required for efficient viral replication in the salivaiy gland, an organ central
to the biology o f CMV. None o f the MCMV m utants tested in th is study grew as
w ell as WT MCMV in the salivaiy glands o f infected mice.
The replication o f RV5 in the salivary glands o f inoculated anim als was
slightly less than th a t o f the WT virus. RV5 reached a peak tite r o f
approxim ately 105 PFU per m l o f organ homogenate, one or two logs less than
th a t o f WT MCMV. Thus, it appears th a t the insertion created in th is m utant
virus disrupts the expression o f an MCMV gene, or genes, influencing salivaiy
gland growth. The lack of this gene product, either directly or indirectly, results
in a slightly reduced ability o f the virus to replicate in the salivary gland. This
finding can be interpreted in one o f three ways. First, it is possible th a t the

78

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

m utation does indeed disrupt an MCMV gene directly involved in viral
replication in the salivaiy gland. This gene product could represent a tissuespecific factor required for e fficient MCMV entry into or growth in salivary gland
serous acinar epithelial cells. However, th is factor does not represent a critica l
or pivotal factor, because the efficiency in replication is only slightly reduced.
More appropriately, it may represent an “accessory” factor for salivaiy glandspecific growth.
Secondly, the m utation m ay not encode a factor specific fo r salivaiy
gland growth, b u t instead, may encode a general factor required fo r efficient
growth in a ll organs o f the infected mouse. In other words, the vira l gene
product indirectly influences sa liva iy gland growth, inasm uch as its absence
decreases the efficiency of MCMV replication in vivo. For example, th is gene
may encode a vira l determ inant fo r entry, dissem ination, or growth in vivo. Or,
it may encode a regulatory protein th a t influences the synthesis o f proteins
expressed from other viral genes required fo r efficient MCMV replication in any
organ, not ju s t in the salivaiy gland. In th is example, the m issing gene product
w ould function nonspecifically to reduce replication in the salivaiy gland, and
w ould not represent a true determ inant o f v ira l growth in th is organ. If this
were the case, then RV5 would also exibit poor growth in a ll other organs o f
infected mice. U nfortunately, conclusions concerning growth in these other
organs cannot be made in th is study.
Lastly, it is possible th a t the reduced tite r o f RV5 in the salivary gland is
not the result o f an MCMV gene disruption, b u t instead is due to the expression
o f the P-glu gene. Mocarski and h is coworkers have observed th a t every one o f
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th e ir lacZ-tagged MCMV m utants evaluated in vivo, regardless o f the insertion
site, has exibited th is organ-specific reduction in peak titers. In addition, th e ir
lacZ-insertion m utants exibited sim ilarly reduced growth patterns in the
salivaiy glands o f im m unodeficient mice (nude and SCID), indicating th a t an
immune reponse to the p-gal protein (encoded by the lacZ gene) did not cause
the lower virus yeilds. W ith many o f these m utants, reduced growth was n o t
observed in any other tissues o f infected mice, only in the salivaiy gland. These
data suggest th a t the expression o f p-gal results in lower virus tite rs specifically
in the salivaiy gland, by an unknow n mechanism. It is possible th a t the
expression o f P-glu in our m utants may cause a sim ilar reduction in salivaiy
gland growth.
The replication o f RV6 in the salivaiy glands o f inoculated mice was
significantly reduced, only reaching peak tite rs o f 103 PFU per m l o f tissue
homogenate, w hich is 4 logs lower than th a t o f WT MCMV. This m utant is
probably defective in the expression o f m ultiple MCMV gene products, and as a
result, replicates poorly in the salivaiy gland. Again, there are several
possibilies to explain th is phenolype. The salivaiy gland plays a central role in
MCMV biology, and there are probably many vira l genes which function to
control tropism to , persistent growth in, and shedding from th is tissue. The
deletion o f only one o f these genes may re su lt in slightly reduced salivaiy gland
titers, such as th a t observed fo r RV5. However, the deletion o f m ultiple genes
influencing salivary gland growth may result in poor replication in th is organ,
such as th a t observed for RV6 and RV7. This study clearly demonstrates th a t
the more extensive the m utation to the MCMV genome, the poorer the a b ility of
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the m u ta n t virus to replicate in the salivaiy gland. These data indicate that
there are many vira l genes influencing salivaiy gland growth, and th a t the
effects o f deleting increasing num bers o f these genes on reducing virus growth
in th is tissue may be additive.
Another possibility, like th a t fo r RV5, is th a t the vira l sequences deleted
in RV6 encode general replication factors required fo r the efficient growth of
MCMV in vivo. The deletion o f two or more o f these factors (possibly occuring in
RV6) w ould result in lower virus tite rs in vivo than w ould be observed if only one
o f these factors were m issing (possibly occuring in RV5). However, since
attenuated virus (tissue-culture-passaged) was used in our in vivo analyses,
neither WT MCMV nor any o f the MCMV m utants grew efficiently in other target
organs o f infected mice. Therefore, determ inations o f WT or m utant virus
growth in the spleen, liver, or lungs o f infected anim als cannot be made in this
study. Regardless, it is clear th a t RV6 grows as efficiently as WT MCMV in
vitro, b u t grows poorly in the salivary glands o f infected anim als, and is

therefore lacking gene products needed fo r efficient MCMV replication in the
salivaiy glands. As a consequence, th is MCMV m utant would also be expected
to e xhibit significantly reduced virus tite rs in saliva, and greatly reduced
transm ission capabilities as compared to WT MCMV.
The replication o f RV7 in the salivaiy glands o f inoculated mice was
dram atically reduced to levels th a t were barely detectable. This finding strongly
suggests th a t m ultiple MCMV genes are involved in salivaiy gland growth,
either directly or indirectly. Presumably, the progressive reduction in salivaiy
gland tite rs observed w ith the m utants in th is study results from the increasing
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num ber o f MCMV genes th a t are disrupted. W hether these genes are involved
in growth specific to the salivaiy gland, or in general vira l replication w ith in the
mouse, cannot be determined at th is tim e. Nevertheless, the genes deleted from
RV7 are necessary fo r MCMV replication in the salivaiy glands o f infected mice,
eventhough they are not required fo r virus growth in cultured fibroblasts.
It is possible th a t one or more o f the genes m issing in RV7 provide
specialized functions th a t are absolutely required fo r MCMV growth in acinar
cells o f the salivaiy gland. The localization o f MCMV to serous acinar epithelial
cells and HCMV to ductal epithelial cells indicates th a t the viruses differ w ith
respect to tropism fo r particular subsets o f epithelial cells present in the
salivaiy gland. Perhaps a gene product m issing in RV7 encodes an MCMV
determ inant governing tropism to this type o f epithelial cell, such as an
envelope glycoprotein necessary fo r attachm ent or penetration.
The drastically reduced growth o f RV7 in the salivaiy glands is probably
n ot the result o f a defect for growth in p rim a iy m urine cells p e r se, because this
m utant replicated as well as WT MCMV in p rim a iy embiyo fibroblasts (derived
from BALB/c mice, the same strain used in o u r in vivo experiments). More
likely, RV7 may be defective for growth in epithelial cells. In vivo, MCMV
characteristically infects epithelial cells, however, p rim aiy epithelial cell lines
are currently not available to test this hypothesis.
Because RV7 displayed a defect in macrophage-specific growth
(discussed in more detail in the following section), perhaps dissem ination to the
salivaiy gland may be compromised by the RV7 m utation. However, th is defect
would not to ta lly explain the lack o f growth o f RV7 in th is organ. In Figure
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13B, RV7 can be detected in the salivaiy glands a t 50 P FU /m l o f homogenate,
on day 14 post-inoculation. This indicates th a t the m u ta n t did reach the
salivaiy gland. But, once reaching th is organ, it did not replicate w ell there,
and could not be detected a t any other tim e p o in t thereafter. If the problem
was p rim arily dissem ination, then once the virus reached the salivary gland,
growth levels sim ilar to WT levels should be observed. Thus, poor
dissem ination may have contributed to, b u t was not the p rim a iy reason for,
poor growth in the salivary gland.
The failure o f RV7 to grow in the salivaiy glands o f inoculated mice is not
the result o f an immune response to the P-glu protein. RV5 and RV6, w hich
also express P-glu, displayed m uch higher tite rs in the salivaiy gland. In
addition, experiments conducted by a collaborating laboratoiy (Dr. H erbert
Virgin, W ashington U niversity, St. Louis, MO) reveal th a t RV7 exhibited
undetectable growth (less th a n 4 PFU /m l o f tissue homogenate) in the salivaiy
glands o f SCID mice, w hich lack a functional im m une system.
RV7 also failed to replicate to detectable levels in the spleen and live r of
inoculated SCID mice (Virgin, personal com m unication). In these
im m unodeficient anim als, WT MCMV replication is never brought under
control, even w ith tissue-culture-passaged virus. Inoculated anim als succumb
to as little as 2 to 3 PFU o f WT virus by 18 to 20 days post-inoculation (Pollack
and Virgin, 1995). Therefore, these mice are veiy sensitive indicators fo r
infectious MCMV. The failure o f RV7 to replicate in these im m unodeficient
mice, strongly suggests th a t RV7 is incapable o f in vivo growth. Thus, it
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appears th a t the v ira l gene products m issing in RV7-infected cells are necessary
to carry out the events required fo r MCMV replication in vivo.
Nonessential MCMV genes encoded w ith in Hind III-J and -I are involved in
macrophage-specific growth
MCMV genes encoded w ith in the nonessential regions o f Hind III-J and -I
are also involved in macrophage-specific growth, because the deletion o f these
sequences results in greatly reduced replication in macrophages. Interactions
between the virus and monocytes/macrophages have been viewed as c ritic a l to
MCMV biology, p a rticula rly in dissem ination and latency. Peripheral blood
monocytes are the only blood cell type w hich are fu lly permissive for MCMV
replication (Collins et al., 1994), and are involved in dissem inating MCMV from
sites o f in itia l replication to a ll other organs o f the infected anim al (Stoddart et
al., 1994). In addition, the monocyte harbors latent virus genomes (Mocarski et
al., 1990), and probably represents the source o f virus spread in blood
transfusions from healthy sero-positive individuals (Kondo et al., 1994).
In IC-21 cells, a fully-differentiated macrophage cell line, RV7 grew 2 to 3
logs less than th a t o f WT MCMV, whereas RV6 grew sim ila rly to the WT virus.
Therefore, the genes influencing macrophage-specific growth are located w ith in
the right-m ost 1.9 kb o f Hind III-J and the left-m ost 3.0 kb o f Hind III-I.
Additional studies in our laboratory using several o f the Mocarski insertion
m utants in Hind III-J (described in Vieira et al., 1994) confirm th a t the deletion
in RV7 is unique in ablating virus growth in macrophages. In fact, each o f the
H ind III-J insertion m utants tested grew sim ilarly to WT MCMV in IC -2 1
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macrophages, indicating th a t the MCMV sequences contained w ith in the left
m ost 3.0 kb o f H ind III-I are responsible for th is phenotype.
The viral genes involved in macrophage-specific growth act following vira l
penetration, during the immediate early phase o f MCMV replication.
Transcription o f the IE1 gene was significantly reduced by 8- to 9-fold in RV7infected IC-21 macrophages. This IE gene is essential for MCMV replication.
Several attem pts to construct IE1 insertion m utants have failed (Mocarski et al.,
1990), and transient transactivation experiments in m urine fibroblasts have
ascribed im portant regulatoiy functions to the IE1 gene product (Keil et al.,
1985 and 1987). It appears th a t the IE1 and IE3 gene products act
synergistically fo r m axim al transactivation o f vira l gene expression.
Consequently, reduced IE1 levels would result in greatly reduced subsequent
vira l gene expression, and greatly reduced virus yeilds. Indeed, this appears to
be the sequence o f events in RV7-infected IC-21 macrophages. Following
reduced IE1 gene expression, the levels o f the e l early tra n scrip t and the gB
late transcript are also significantly reduced. These data correlate w ith the
decreased virus yeilds from these macrophages.
There are differences in the regulation o f the immediate early phases of
HCMV gene expression in fibroblasts versus macrophages (Keny et al., 1995).
A 1.4 kb mRNA from the m ajor IE gene region o f HCMV was n o t detectable
during a norm al infection o f hum an fibroblasts, b u t was readily detected in
infected hum an macrophages a t immediate eaiyl tim es. These results suggest
th a t th is IE gene product exhibits cell type-specific expression, and may be
im portant in the regulation o f HCMV infection in macrophages. Perhaps the
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m utation in RV7 deletes an MCMV homologue to th is HCMV IE gene product,
and thereby blocks the course o f subsequent v ira l gene expression in m urine
macrophages, b u t has no effects on gene expression in fibroblasts.
It is also possible th a t a host factor present in fibroblasts, b u t absent in
macrophages, can functionally compensate fo r the m issing vira l gene products
in RV7. For example, herpesviruses in general encode m any o f the enzymes
required fo r vira l DNA synthesis, and m ost o f these enzymes are counterparts o f
cellular enzymes, but have different substrate specificities and regulatory
properties (Roizman et al., 1987). Some host enzymes can complement, in part,
vira l requirem ents for these functions. And some HSV-1 m utants grow better in
some cell lines than in others (Roizman et al., 1985).
An intrig u in g possibility is th a t the deletion in RV7 encodes a virion
stru ctu ra l protein, such as a tegument protein, w hich is delivered into the cell
upon virus penetration and functions to enhance immediate early transcription
in macrophages, b u t is n o t necessary fo r immediate early transcription in
fibroblasts. Although th is possibility is purely speculative, both HCMV and
HSV encode tegum ent proteins th a t enhance immediate early transcription in
permissive cells (Liu and S tinski, 1992; Roizman, 1990b). And yet another
possibility is th a t the DNA sequence deleted in RV7 contains an enhancer
region required fo r efficient immediate early transcription in macrophages, b u t
n ot needed for immediate early transcription in fibroblasts. The promoter for
the m ajor IE genes o f MCMV, IE1 and IE3, is located in relatively close
proxim ity to the RV7 deletion, less than 7 kb downstream (leftward on the
MCMV genome).
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In summary, the salivaiy gland and the macrophage play key roles in
MCMV pathogenesis. The failure o f RV7 to replicate in the salivary glands, and
its greatly reduced a b ility to replicate in macrophages, strongly suggest th a t the
MCMV sequences deleted in th is m utant are crucial fo r MCMV pathogenesis in
vivo, p a rticula rly in virus growth, persistence, transm ission, dissem ination, and

latency.
Continued studies include finer deletion mapping o f the Hind III-I region
by constructing additional m utants containing deletions o f subregions o f the
RV7 deletion. In th is way, MCMV sequences involved in macrophage-specific
growth and salivaiy gland-specific growth can be better defined. Future studies
also include transfecting NIH3T3 fibroblasts w ith the m iddle 3.0 kb Sst I
fragm ent o f H ind III-I, w hich encodes an essential gene fo r MCMV replication in
vitro, and infecting these cells w ith RV9. The stably integrated MCMV DNA

fragm ent should provide the essential gene product in trans, and the isolation of
a pure RV9 stock should be possible. This m utant can then be analyzed to
identify the essential MCMV gene product(s).
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FIGURE 1. A schematic diagram o f the sequence arrangements in the HCMV
and MCMV genomes. In the HCMV genome, DNA sequences from both te rm ini
are repeated in an inverted orientation and positioned side-by-side internally,
dividing the genome into two components o f unique sequences, Us and U l , each
flanked by inverted repeats. The MCMV genome consists entirely o f unique
DNA sequences. U l and Us, unique sequences o f the long and short
components, respectively; T R l and TRs, term inal repeat sequences o f the long
and short components, respectively; I R l and IRs, inverted repeat sequences o f
the long and short components, respectively.
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TABLE X. Nonessential viral genes th a t are known to, or are predicted to,
influence pathogenesis in vivo. These examples were compiled from: Gooding,
1992; Johnson et al., 1995; Jones et al., 1995; McCance et al., 1995; Symons
et al., 1995. Abbreviations: Ad, adenovirus; EBV, Epstein-Barr virus; elF,
eukaryotic translation initia tio n factor; IFN, interferon; IL, interleukin; HCMV,
hum an cytomegalovirus; HSV, herpes simplex virus; HPV, hum an
papillom avirus; MHC, major histocom patibility complex; TNF, tum or necrosis
factor.
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TABLE 1. Nonessential V ira l Genes th a t M odulate
Pathogenesis
V irus Fam ily

V irus

Gene Product

Function

Adenoviruses

Ad2

E 3 -g p l9 k
E3-14.7k
E 3-10.4/14.5k
E1A

reduces MHC class I
inh ib its TNF-mediated lysis
inh ib its TNF-mediated lysis
inh ib its MHC class I mRNA

A d l2

Poxviruses

Myxoma
Vaccinia

T2
C21L
B15R
E3L
IFN-yR
K3L

in h ib its TNF
inhibits complement
in h ib its IL -ip
inh ib its IF N -a/p
in h ib its IFN-y
inh ib its eIF2a

Herpesviruses

EBV

EBER RNA
BCRF1
US2-5
US11
gC-1
gE-gl
ICP47

inh ib its IF N -a/p
IL-10 homologue
reduces MHC class I
reduces MHC class I
inhibits complement
in h ib its antibody neutralization
reduces MHC class I

E5

reduces MHC class I

HCMV
H SV-1/2

Papillomaviruses

HPV-16
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FIGURE 2. (A) Schem atic o f the w ild -typ e S m ith s tra in MCMV genome, w hich is 230 kilobase p a irs in length. (B)
Expansion o f the H ind III-J and -I regions, showing the locations o f H ind III (H) and Sst I (Ss) sites, and fragm ent sizes
in kilobase (kb) pairs. (C) Locations o f the nonessential HCMV genes (IRS1 and US1 through US13 o f the AD169 strain)
aligned according to m ap u n its w ith the MCMV H ind III-J and -I fragm ents.
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FIGURE 4. O rganizations o f plasm ids used to generate MCMV recom binant
viruses. (A) Plasmid p e l/P -g lu carries an Sst I to Nco I fragm ent (0.2 kilobase
[kb] pairs) from the MCMV early region 1 (el) prom oter (indicated as a stippled
box) coupled to the Nco I to Sst I fragm ent (2.2 kb) o f the p-glu gene (indicated
as the hatched rectangle). This 2.4 kb e l/p -g lu cassette was cloned into the
Sst I site o f the plasm id vector pGEM-7Z (indicated as solid rectangles). (B)
Plasmid p 3 .4 jp g lu contains the firs t 3.4 kb o f MCMV H ind III-J sequences
(illustrated as an open rectangle) coupled to the e l/p -g lu cassette. The solid
rectangles represent vector sequences o f the pGEM-4Z plasm id. (C)
Organization o f recom bination plasm ids. The th in horizontal lines represent an
expansion o f the MCMV H ind III-J and -I fragm ents (indicated by opposing
arrows), showing re striction endonuclease sites fo r Bgl II (B), Hind III (H), and
Sst I (S), as w ell as the distance between these sites (indicated in kb). The
vertically slanted lines illu stra te those MCMV sequences (shown as open
rectangles) used to construct the indicated recom bination plasm ids. Vector
sequences o f pGEM-4Z are shown as solid rectangles. Recombination plasmid
p jp g lu -5 carries the e l/P -g lu cassette inserted a t the second Sst I site in Hind
III-J . The rem aining recom bination plasm ids were constructed using p3.4jpglu
opened a t the 3’ end o f the p-glu gene. To construct p jp g lu -6 , the 1.9 kb Sst I
fragm ent o f H ind III-J was cloned behind the cassette. To create pJiPglu-7, the
middle 3.0 kb Sst I fragm ent o f Hind III-I was cloned behind the cassette. To
generate pJiPglu-9, the 3.7 kb Sst I fragm ent o f H ind III-I was cloned behind
the cassette.
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FIGURE 5 . Transfection o f MCMV DNA results in productive infection. V arious am ounts o f p u rifie d MCMV DNA (1, 2,

3, 4, o r 5 pg) were transfected in to NIH3T3 fib ro bla sts using a m odified calcium phosphate p re cip ita tio n technique. A
to ta l o f 7 pg o f DNA (MCMV DNA and c a lf thym us DNA, as a carrier) was transfected in to 3 X 106 cells in suspension
and placed in to a 100-m m tissue c u ltu re plate. The cells were shocked w ith 20% d im e thyl sulfoxide a t 5 hours post
transfection, and then were overlayed w ith 0.5% agarose the follow ing day. One week later, the cell m onolayer was
fixed w ith 10% buffered form alin, stained w ith crysta l violet, and viru s plaques were counted.

ug MCMV

CO

DNA

£
Q

a
o
-4J

o

CO
ti

CO
«-i

H

o
o

o

CO

CM

to

o
o

CM

o

to

o

o
T"

o
in

o

109

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

FIG URE 6 . In se rtio n and deletion m u ta n ts o f the MCMV H ind III-J and -I fragm ents. The e l/p -g lu cassette, illu s tra te d

as a stippled rectangle, was inserted a t the second Sst I site w ith in MCMV H ind III-J to generate recom binant v iru s 5
(RV5). RV6, RV7, and RV9 are deletion m u ta n ts in w hich the hatched areas represent the locations o f MCMV genomic
sequences th a t were deleted and replaced w ith the e l/p -g lu cassette. The num bers follow ing each rectangle indicate the
sizes o f the e l/p -g lu cassette (stippled rectangle) o r o f the deletions (hatched rectangles) in kilobase (kb) pairs. H
indicates H ind III sites, and Ss indicates Sst I sites.
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FIGURE 7. Southern b lo t analyses o f recom binant MCMV. DNA was isolated
from NIH3T3 cells th a t were mock-infected (M), or infected w ith wild-type (WT)
virus o r the indicated recom binant virus (RV) for 24 hours. The DNA was
digested w ith H ind III + Bgl II, or w ith Bgl II alone, and was analyzed by
Southern blot. DNA probes o f MCMV H ind III-J (J), H ind III-I (I), and the pglucuronidase (P-glu) gene were labeled w ith DIG-dNTP using the random
primed method. H ybridization was visualized by chem ilum inescent detection
using the Boehringer Mannheim Genius System. For RV5 and RV6, the oddnumbered lanes indicate digestion w ith H ind III + Bgl II, and the evennumbered lanes indicate digestion w ith Bgl II alone. For RV7 and RV9, the
infected cell DNAs were digested w ith H ind III + Bgl II. For RV7, lanes 3 and 4
represent DNA isolated from cells infected w ith independent isolates o f this
m utant, and lane 5 represents the recom bination plasm id used to generate
RV7. RV9-infected cell DNA is represented in lane 7, and its recombination
plasm id in lane 8. Sizes o f the DNA fragments are indicated in kilobase (kb)
pairs.
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TABLE 2. Hybridizing DNA fragm ents expected in Southern blot analyses o f
MCMV m utants. Fragm ent sizes resulting from digestion o f infected cell DNAs
w ith the indicated re strictio n endonucleases and hybridization w ith the
indicated probes are listed in kilobase (kb) pairs. Sizes were determined from
the restriction endonuclease map o f the MCMV Hind III-J and -I regions (see
Figs. 3 and 4). The e l/p -g lu cassette is 2.4 kb in length, and does n o t contain
any sites for either H ind III o r Bgl II.
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Southern Blot Analysis - Sizes of Expected Bands in Kilobase Pairs

Virus

Probe

Digestion o f DNA
w ith Hind III + Bgl n

Digestion of DNA w ith
B glH

WT
MCMV

J
I

2.0, 2.8, 3.3
1.0, 1.7, 2.8, 4.2

2.0, 2.8, 5.1

RV5

J
P-glu

2.0, 2.8, 5.7
5.7

2.0, 2.8, 7.4
7.4

RV6

J
p-glu

2.8, 4.9
4.9

2.8, 6.7
6.7

RV7

J
I
p-glu

2.8, 6.0
1.0, 2.7, 6.0
6.0

RV9

J
I
p-glu

2.8, 4.0
2.7, 4.0
4.0
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FIGURE 8 . In intro grow th o f MCMV m u ta n ts in fib ro bla sts. M u lti-ste p grow th curves o f each recom binant viru s (RV)
were determ ined in NIH3T3 fib ro bla sts (A) and in p rim a ry em bryo fib ro bla sts (B). Tissue cu ltu re fla sks (25 cm 2) were
seeded w ith 5 X 105 cells in 5 m l o f media. The follow ing day, the cells were infected w ith w ild-type (WT) viru s o r the
indicated m u ta n t viru s (RV) a t a m u ltip lic ity o f 0.1 plaque-form ing u n its (PFU) per cell. A t the indicated tim es post
infection, to ta l v iru s was harvested and titered by standard plaque assay on NIH3T3 cells. Bach datum p o in t
represents the average o f two separate cu ltu res, and the standard deviation o f the geom etric mean is indicated by the
e rro r bars. The m inim um level o f detection was 10 P FU /m l.
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FIGURE 9. In intro grow th o f MCMV m u ta n ts in macrophages. M u lti-ste p (A) and one-step (B) grow th curves o f each
recom binant v iru s (RV) were determ ined in 1C-21 m acrophages. Tissue c u ltu re fla sks (25 cm 2) were seeded w ith 1 X 106
cells in 5 m l o f media. The follow ing day, the cells were infected w ith w ild-type (WT) v iru s o r the indicated m u ta n t (RV)
a t a m u ltip lic ity o f 0.1 plaque-form ing u n its (PFU) per ce ll (for the m u lti-ste p grow th curves), o r 5 PFU per cell (for the
one-step grow th curves). A t the indicated tim es post-infection, to ta l v iru s was harvested and titered by standard plaque
assay on NIH3T3 cells. Each datum p o in t represents the average o f two separate cu ltu re s, and the standard deviation
o f the geometric m ean is indicated by the e rro r bars. The m inim um level o f detection was 10 P FU /m l.
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FIGURE 10. N orthern b lo t analyses o f immediate early (IE), early (E), and late
(L) RNAs from RV7-infected cells. Tissue culture plates were seeded w ith 2 X
106 NIH3T3 o r IC-21 cells. The following day, the cells were mock-infected (M),
or were infected w ith w ild-type (WT) virus o r the indicated recom binant virus
(RV) a t a m u ltip licity o f 4 plaque-form ing u n its (PFU) per cell. Total RNA was
isolated from infected cells under immediate early, early, o r late conditions
(using the Qiagen RNeasy Kit), and was hybridized to probes of known IE, E, or
L genes, respectively. IE RNA was isolated a t 3 hours post-infection, and was
hybridized to a probe o f the MCMV H ind III-L fragm ent (containing the IE1 and
IE2 genes). E RNA was isolated a t 24 hours post-infection in the presence of
phosphonoacetic acid (250 pg/m l), and was hybridized to a probe o f the early
region 1 (el) gene. L RNA was isolated a t 24 hours post-infection, and was
hybridized to a probe o f the glycoprotein B (gB) gene. DNA probes were labeled
w ith DIG-dNTP using the random primed method, and hybridization was
visualized by chem ilum inescent detection using the Boehringer Mannheim
Genius System. Sizes o f the RNA transcripts are indicated in kilobase (kb)
pairs. In a ll blots, 5 pg o f total RNA was electrophoresed per lane.
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FIGURE 11. In vitro analysis o f RV7 entry into fibroblasts and macrophages.
Duplicate tissue culture plates were seeded w ith 2 X 106 NIH3T3 fibroblasts or
IC-21 macrophages. The following day, the cultures were mock-infected (M), or
were infected w ith w ild-type (WT) virus o r the indicated recom binant virus (RV)
a t a m u ltip licity o f 4 plaque-form ing u n its (PFU) per cell. A t 3 hours post
infection, RNA was harvested from one culture fo r Northern blot analysis, and
DNA was harvested from the other culture fo r Southern b lo t analysis. For the
Southern blot, infected cell DNAs were digested w ith Hind III, 10 pg o f digested
DNA was electrophoresed per lane, and the blot was hybridized to a probe o f the
MCMV Hind III-L fragm ent. For the Northern blot, 5 pg o f to ta l RNA was
electrophoresed per lane, and the b lo t was also hybridized to a probe o f Hind
III-L . Sizes o f the MCMV H ind III-L fragm ent and the IE1 RNA tra n scrip t are
indicated in kilobase (kb) pairs.
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FIGURE 1 2 . Effects o f MCMV m u ta n ts on the expression o f MHC class I. W T-19 fib ro bla sts were m ock-infected (M), o r

were infected w ith w ild-type (WT) v iru s o r the indicated recom binant viru s (RV) a t a m u ltip lic ity o f 2 plaque-form ing
u n its (PFU) per cell fo r 24 hours. Cells were pulsed w ith 50 U /m l o f gamma interferon fo r 24 hours p rio r to infection.
C ell lysates were prepared and precleared overnight w ith mouse IgG. The H -2K b class I heavy chain was detected by
W estern b lo t using the ECL m ethod (Amersham Life Science) w ith anti-peptide 8 (ra b b it IgG served as a negative
control) and HRP-conjugated a n ti-ra b b it antibodies. The H -2Kb heavy chain, m ig ra tin g a t 46 kilo d a lton s (kd) is
indicated.

RV5
WT

RV5

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

FIGURE 1 3 . G row th o f MCMV m u ta n ts in the salivary glands o f infected mice. Three-week-old B A L B /c.B yJ mice were

inoculated w ith 1.5 X 105 plaque-form ing u n its (PFU) o f w ild-type (WT) viru s o r the indicated recom binant viru s (RV) by
intraperitoneal injection. (A) A t 3, 7, 10, and 14 days p o st-inoculation, mice were sacrificed and th e ir subm axillary
salivary glands were harvested. The organs were in d iv id u a lly weighed, and a 20% (w eight/volum e) homogenate was
prepared and tite re d on NIH3T3 cells by standard plaque assay. Each datum p o in t represents the average o f 3 anim als,
and the standard deviation o f the geom etric mean is indicated by the e rro r bars. (B) A t 2, 4, and 6 weeks post
inoculation, the salivary glands from 3 to 4 anim als were pooled, homogenized, and titered. The m inim u m level o f
detection was 10 P FU /m l.
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FIGURE 14. G row th o f MCMV m u ta n ts in the footpads o f infected mice. Eight-w eek-old B A LB /c.B yJ mice were
anesthetized and injected subcutaneously w ith 1.5 X 105 plaque-form ing u n its (PFU) o f w ild-type (WT) viru s o r the
indicated recom binant v iru s (RV) in each h in d footpad. A t 4 days po st-ino cu latio n , mice were sacrificed and th e ir
footpad tissue was removed. A 10% (w eight/volum e) homogenate was prepared and titered on NIH3T3 cells by
standard plaque assay. Each colum n represents the pooled footpads from 2 anim als. The m inim um level o f detection
was 10 P FU /m l.
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FIGURE 15. T ra n scrip ts and ORFs encoded w ith in MCMV H in d III-J . (A) The MCMV H ind III-J fragm ent, showing
re stric tio n sites fo r H ind III (H) and S st I (S). (B) RNA tra n s crip ts encoded w ith in the H in d III-J region. E designates
early tra n scrip ts, L designates late tra n s crip ts , and num bers indicate the sizes o f the tra n s c rip ts in kilobase (kb) pairs.
The arrow s indicate the d ire ctio n o f tra n scrip tio n . The s ta rt sites o f the E 4.1, 6.0, and 7.4 kb tra n s c rip ts lie in the
adjacent H ind III-I region (indicated by the dashed line). (C) Arrangem ent o f the predicted open reading fram es (ORFs)
encoded w ith in the H ind III-J fragm ent. The positions o f p utative TATA boxes fo r leftw ard-oriented prom oters are
indicated by the leftw a rd-p o in tin g arrow s. The positions o f p o te n tial polyadenylation signals are indicated by the
ve rtica l arrow s. (This data was taken from V ieira e t a l., Jo u rn a l o f Virology, 68:4837-4846, 1994.) (D) Locations o f the
RV5 inse rtio n m u ta tio n (indicated by the ve rtica l arrow ) and the RV6 and RV7 deletion m u ta tio n s (indicated by the
hatched rectangles). The RV7 deletion continues in to the adjacent H ind III-I fragm ent o f MCMV (see Fig. 16).
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FIGURE 16. T ra n crip ts and p o te n tia l ORFs encoded w ith in MCMV H ind III-I. (A) The MCMV H ind III- I fragm ent,
showing re s tric tio n sites fo r H ind III (H) and S st I. (B) RNA tra n sc rip ts in itia tin g w ith in H ind III-I and te rm in a tin g
w ith in the adjacent H ind III-J fragm ent (indicated by the dashed lines). E designates early tra n scrip ts, and num bers
indicate the sizes o f the tra n s crip ts in kilobase (kb) pairs. The arrow s indicate the d ire ctio n o f tra n scrip tio n . (C)
Arrangem ent o f the predicted open reading fram es (ORFs) encoded w ith in the H ind III-I fragm ent (w hich are oriented in
the leftw ard d ire ctio n on the MCMV genome). (D) Locations o f the RV7 and RV9 deletion m u ta tio ns, indicated by the
hatched rectangles. B oth deletions continue in to the adjacent H ind III-J fragm ent o f MCMV (see Fig. 15).
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